All Stories

  1. Whole genome sequencing analysis demonstrates therapy‐induced echinocandin resistance in Candida auris isolates

    Article • Mycoses, September 2023, Wiley

    Dr Jacques F Meis

  2. The Fourier-transform infrared spectroscopy-based method as a new typing tool for Candida parapsilosis clinical isolates

    Article • Microbiology Spectrum, September 2023, ASM Journals

    Dr Jacques F Meis

  3. Genotyping and susceptibility testing uncovers large azole-resistant Candida tropicalis clade in Alexandria, Egypt

    Article • Journal of Global Antimicrobial Resistance, September 2023, Elsevier

    Dr Jacques F Meis

  4. Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in ERG2 as a Major Mechanism Conferring Reduced Susceptibility to Amphotericin B in Candida kefyr

    Article • Microbiology Spectrum, August 2023, ASM Journals

    Dr Jacques F Meis

  5. Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study

    Article • Mycopathologia, August 2023, Springer Science + Business Media

    Dr Jacques F Meis

  6. In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris

    Article • Medical Mycology, July 2023, Oxford University Press (OUP)

    Dr Jacques F Meis

  7. Application of Novel Short Tandem Repeat Typing for Wickerhamomyces anomalus Reveals Simultaneous Outbreaks within a Single Hospital

    Article • Microorganisms, June 2023, MDPI AG

    Dr Jacques F Meis

  8. Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

    Article • The Lancet Infectious Diseases, June 2023, Elsevier

    Dr Jacques F Meis

  9. Tackling Histoplasmosis Infection in People Living with HIV from Latin America: From Diagnostic Strategy to Public Health Solutions

    Article • Journal of Fungi, May 2023, MDPI AG

    Dr Jacques F Meis

  10. Epidemiological features of nosocomial candidaemia in neonates, infants and children: A multicentre study in Iran

    Article • Mycoses, April 2020, Wiley

    Dr Jacques F Meis, Dr Fatemeh Ahangarkani

  11. First azole‐resistant Aspergillus fumigatus isolates with the environmental TR 46 /Y121F/T289A mutation in Iran

    Article • Mycoses, March 2020, Wiley

    Dr Hamid Badali, Dr Jacques F Meis, Dr Fatemeh Ahangarkani

  12. Development of Candida auris Short Tandem Repeat Typing and Its Application to a Global Collection of Isolates

    Article • mBio, February 2020, ASM Journals

    Dr Jacques F Meis

  13. Genotypic diversity in clinical and environmental isolates ofCryptococcus neoformansfrom India using multilocus microsatellite and multilocus sequence typing

    Article • Mycoses, January 2020, Wiley

    Dr Jacques F Meis

  14. Candida auris—“Ten Years After”

    Article • Journal of Fungi, December 2019, MDPI AG

    Dr Jacques F Meis

  15. Multiresistant Fusarium Pathogens on Plants and Humans: Solutions in (from) the Antifungal Pipeline?

    Article • Infection and Drug Resistance, November 2019, Taylor & Francis

    Dr Jacques F Meis

  16. cyp51A Mutations, Extrolite Profiles, and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex

    Article • Antimicrobial Agents and Chemotherapy, November 2019, ASM Journals

    Dr Jacques F Meis

  17. External Quality Assessment Evaluating the Ability of Dutch Clinical Microbiological Laboratories to Identify Candida auris

    Article • Journal of Fungi, October 2019, MDPI AG

    Dr Jacques F Meis

  18. Development of Candida auris microsatellite typing and its application on a global collection of isolates

    Article • October 2019, Cold Spring Harbor Laboratory Press

    Dr Jacques F Meis

  19. Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting

    Article • International Journal of Antimicrobial Agents, October 2019, Elsevier

    Dr Jacques F Meis, Mr Martin A Kiernan

  20. The First Two Cases of Candida auris in The Netherlands

    Article • Journal of Fungi, September 2019, MDPI AG

    Dr Jacques F Meis

  21. ECMM Candi Reg—A ready to use platform for outbreaks and epidemiological studies

    Article • Mycoses, August 2019, Wiley

    Dr Jacques F Meis

  22. In vitro activity of nine antifungal agents against a global collection of Hortaea werneckii isolates, the agent of tinea nigra

    Article • International Journal of Antimicrobial Agents, July 2019, Elsevier

    Dr Hamid Badali, Dr Jacques F Meis, Dr Fatemeh Ahangarkani

  23. Invasive Aspergillosis by Aspergillus flavus: Epidemiology, Diagnosis, Antifungal Resistance, and Management

    Article • Journal of Fungi, July 2019, MDPI AG

    Dr Jacques F Meis

  24. A simple and low cost tetra-primer ARMS-PCR method for detection triazole-resistant Aspergillus fumigatus

    Article • Molecular Biology Reports, June 2019, Springer Science + Business Media

    Dr Hamid Badali, Dr Jacques F Meis

  25. Does Online Search Behavior Coincide with Candida auris Cases? An Exploratory Study

    Article • Journal of Fungi, June 2019, MDPI AG

    Dr Jacques F Meis

  26. Nonrandom Distribution of Azole Resistance across the Global Population of Aspergillus fumigatus

    Article • mBio, May 2019, ASM Journals

    Professor Matthew C Fisher, Dr Jacques F Meis

  27. Killing ofCandida aurisby UV-C: Importance of exposure time and distance

    Article • Mycoses, March 2019, Wiley

    Dr Jacques F Meis

  28. Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America

    Article • Mycologia, March 2019, Taylor & Francis

    Dr Jacques F Meis, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  29. Candida auris otomycosis in Iran and review of recent literature

    Article • Mycoses, January 2019, Wiley

    mahdi abastabar, Dr Hamid Badali, Dr Jacques F Meis, Dr Fatemeh Ahangarkani

  30. Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus

    Article • Journal of Fungi, December 2018, MDPI AG

    Dr Jacques F Meis

  31. Invasive Infections Due to Trichosporon: Species Distribution, Genotyping, and Antifungal Susceptibilities from a Multicenter Study in China

    Article • Journal of Clinical Microbiology, November 2018, ASM Journals

    Dr Jacques F Meis

  32. ERG6 and ERG2 Are Major Targets Conferring Reduced Susceptibility to Amphotericin B in Clinical Candida glabrata Isolates in Kuwait

    Article • Antimicrobial Agents and Chemotherapy, November 2018, ASM Journals

    Dr Jacques F Meis

  33. Nontypeable Haemophilus influenzae Invasive Blood Isolates Are Mainly Phosphorylcholine Negative and Show Decreased Complement-Mediated Killing That Is Associated with Lower Binding of IgM and CRP in Comparison to Colonizing Isolates from the Oropharynx

    Article • Infection and Immunity, November 2018, ASM Journals

    Dr Jacques F Meis

  34. Perspectives on misidentification of Trichophyton interdigitale /Trichophyton mentagrophytes using internal transcribed spacer region sequencing: Urgent need to update the sequence database

    Article • Mycoses, November 2018, Wiley

    Dr Jacques F Meis

  35. Epidemiology of Aspergillus species causing keratitis in Mexico

    Article • Mycoses, October 2018, Wiley

    Dr Hamid Badali, Dr Jacques F Meis

  36. Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant Aspergillus fumigatus Isolates

    Article • Journal of Fungi, August 2018, MDPI AG

    Dr Jacques F Meis

  37. Post-influenzal triazole-resistant aspergillosis following allogeneic stem cell transplantation

    Article • Mycoses, June 2018, Wiley

    Dr Jacques F Meis

  38. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene

    Article • Mycoses, April 2018, Wiley

    Dr Jacques F Meis

  39. An outbreak due to Candida auris with prolonged colonization and candidemia in a tertiary care European hospital

    Article • Mycoses, April 2018, Wiley

    Dr Jacques F Meis

  40. Comparative virulence of Candida auris with Candida haemulonii , Candida glabrata and Candida albicans in a murine model

    Article • Mycoses, March 2018, Wiley

    Dr Jacques F Meis, Dr Hamid Badali, Dr Eric Dannaoui

  41. Triazole resistance surveillance in Aspergillus fumigatus

    Article • Medical Mycology, March 2018, Oxford University Press (OUP)

    Dr Jacques F Meis

  42. Fusarium metavorans sp. nov.: The frequent opportunist ‘FSSC6’

    Article • Medical Mycology, March 2018, Oxford University Press (OUP)

    Dr Jacques F Meis

  43. Current antifungal treatment of fusariosis

    Article • International Journal of Antimicrobial Agents, March 2018, Elsevier

    Dr Jacques F Meis, Pr Stephane Ranque

  44. Emergence of azole resistant Aspergillus fumigatus and One Health: time to implement environmental stewardship

    Article • Environmental Microbiology, February 2018, Wiley

    Dr Jacques F Meis

  45. Pharmacodynamics of Voriconazole for Invasive Pulmonary Scedosporiosis

    Article • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals

    Dr Jacques F Meis

  46. Development of Echinocandin Resistance inCandida tropicalisfollowing Short-Term Exposure to Caspofungin for Empiric Therapy

    Article • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals

    Professor Suhail Ahmad, Dr Jacques F Meis

  47. Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients

    Article • Microbial Pathogenesis, February 2018, Elsevier

    Dr Jacques F Meis, Prof. Tahereh Shokohi, Dr Hamid Badali, Dr Fatemeh Ahangarkani

  48. Environmental distribution of Cryptococcus species and some other yeast-like fungi in India

    Article • Mycoses, January 2018, Wiley

    Dr Jacques F Meis

  49. Differential In Vitro Cytokine Induction by the Species of Cryptococcus gattii Complex

    Article • Infection and Immunity, January 2018, ASM Journals

    DR Flavio Queiroz-Telles, Dr Jacques F Meis

  50. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry

    Article • BMC Infectious Diseases, January 2018, Springer Science + Business Media

    Dr Jacques F Meis, mahdi abastabar, Dr Hamid Badali

  51. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review

    Article • Mycoses, January 2018, Wiley

    Dr Rasoul Mohammadi, Dr Jacques F Meis, Dr Hamid Badali, Javad Javidnia

  52. Differential Kinetics of Aspergillus nidulans and Aspergillus fumigatus Phagocytosis

    Article • Journal of Innate Immunity, December 2017, Karger Publishers

    Dr Jacques F Meis

  53. Use of cell surface protein typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran

    Article • Mycoses, November 2017, Wiley

    Dr Hamid Badali, Dr Jacques F Meis, Prof. Tahereh Shokohi, mahdi abastabar

  54. Ecoepidemiology of Cryptococcus gattii in Developing Countries

    Article • Journal of Fungi, November 2017, MDPI AG

    Dr Jacques F Meis, DR Flavio Queiroz-Telles

  55. Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs

    Article • Journal of Antimicrobial Chemotherapy, November 2017, Oxford University Press (OUP)

    Dr Jacques F Meis

  56. Antifungal Susceptibility of Emerging Dimorphic Pathogens in the Family Ajellomycetaceae

    Article • Antimicrobial Agents and Chemotherapy, October 2017, ASM Journals

    Dr Jacques F Meis

  57. Molecular Diagnostics of Arthroconidial Yeasts, Frequent Pulmonary Opportunists

    Article • Journal of Clinical Microbiology, October 2017, ASM Journals

    Professor Macit Ilkit, Dr Jacques F Meis

  58. Molecular Characterization and Antifungal Susceptibility Testing of Sequentially Obtained Clinical Cryptococcus deneoformans and Cryptococcus neoformans Isolates from Ljubljana, Slovenia

    Article • Mycopathologia, October 2017, Springer Science + Business Media

    Dr Jacques F Meis

  59. Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs

    Article • Journal of Antimicrobial Chemotherapy, October 2017, Oxford University Press (OUP)

    Dr Jacques F Meis

  60. Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study

    Article • Medical Mycology, October 2017, Oxford University Press (OUP)

    Dr Jacques F Meis

  61. Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients

    Article • Antimicrobial Agents and Chemotherapy, September 2017, ASM Journals

    DR Flavio Queiroz-Telles, Dr Jacques F Meis

  62. In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris

    Article • Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals

    Dr Hamid Badali, Dr Jacques F Meis, Dr Eric Dannaoui

  63. Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment

    Article • The Journal of Infectious Diseases, August 2017, Oxford University Press (OUP)

    Dr Jacques F Meis

  64. The first cases of Candida auris candidaemia in Oman

    Article • Mycoses, July 2017, Wiley

    Dr Jacques F Meis

  65. A Novel Environmental Azole Resistance Mutation inAspergillus fumigatusand a Possible Role of Sexual Reproduction in Its Emergence

    Article • mBio, June 2017, ASM Journals

    Dr Jacques F Meis

  66. Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

    Article • PLoS Pathogens, May 2017, PLOS

    Dr Jacques F Meis

  67. Antifungal Susceptibility Testing of Fusarium: A Practical Approach

    Article • Journal of Fungi, April 2017, MDPI AG

    Dr Jacques F Meis

  68. Whole Genome-Based Amplified Fragment Length Polymorphism Analysis Reveals Genetic Diversity in Candida africana

    Article • Frontiers in Microbiology, April 2017, Frontiers

    Dr Jacques F Meis, Dr Hamid Badali

  69. Neonatal Cutaneous Invasive Aspergillosis Accompanied by Hemophagocytic Lymphohistocytosis

    Article • The Pediatric Infectious Disease Journal, April 2017, Wolters Kluwer Health

    Dr Jacques F Meis

  70. Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    Dr Jacques F Meis, M.D; Ph.D; FIDSA Carlos Alvarez-Moreno

  71. Intercountry Transfer of Triazole-Resistant Aspergillus fumigatus on Plant Bulbs

    Article • Clinical Infectious Diseases, March 2017, Oxford University Press (OUP)

    Dr Jacques F Meis

  72. Low sensitivity of implant sonication when screening for infection in revision surgery

    Article • Acta Orthopaedica, March 2017, Taylor & Francis

    Dr Jacques F Meis

  73. Imported Talaromycosis in Oman in Advanced HIV: A Diagnostic Challenge Outside the Endemic Areas

    Article • Mycopathologia, March 2017, Springer Science + Business Media

    Dr Jacques F Meis

  74. Global Population Genetic Analysis of Aspergillus fumigatus

    Article • mSphere, February 2017, ASM Journals

    Dr Jacques F Meis, Jianping Xu

  75. In Vitro Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination

    Article • Antimicrobial Agents and Chemotherapy, January 2017, ASM Journals

    Dr Jacques F Meis

  76. Molecular and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Characterization of Clinically Significant Melanized Fungi in India

    Article • Journal of Clinical Microbiology, January 2017, ASM Journals

    Dr Jacques F Meis

  77. Routine identification of Nocardia species by MALDI-TOF mass spectrometry

    Article • Diagnostic Microbiology and Infectious Disease, January 2017, Elsevier

    Dr Jacques F Meis

  78. Fusariumspecies causing eumycetoma: Report of two cases and comprehensive review of the literature

    Article • Mycoses, December 2016, Wiley

    Dr Jacques F Meis

  79. Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015

    Article • Emerging Microbes & Infections, December 2016, Springer Science + Business Media

    Dr Jacques F Meis

  80. Cryptococcus neoformans population diversity and clinical outcomes of HIV-associated cryptococcal meningitis patients in Zimbabwe

    Article • Journal of Medical Microbiology, November 2016, Society for General Microbiology

    Dr Jacques F Meis

  81. Pharmacodynamics of Voriconazole against Wild-Type and Azole-Resistant Aspergillus flavus Isolates in a Nonneutropenic Murine Model of Disseminated Aspergillosis

    Article • Antimicrobial Agents and Chemotherapy, November 2016, ASM Journals

    Dr Seyedmojtaba Seyedmousavi, Dr Jacques F Meis

  82. In-host adaptation and acquired triazole resistance in Aspergillus fumigatus : a dilemma for clinical management

    Article • The Lancet Infectious Diseases, November 2016, Elsevier

    Dr Jacques F Meis

  83. In vitro antifungal susceptibility profiles of Cryptococcus species isolated from HIV-associated cryptococcal meningitis patients in Zimbabwe

    Article • Diagnostic Microbiology and Infectious Disease, November 2016, Elsevier

    Dr Jacques F Meis

  84. Clinical implications of globally emerging azole resistance inAspergillus fumigatus

    Article • Philosophical Transactions of the Royal Society B Biological Sciences, October 2016, Royal Society Publishing

    Dr Jacques F Meis, Professor Matthew C Fisher

  85. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species

    Article • Antimicrobial Agents and Chemotherapy, October 2016, ASM Journals

    Dr Jacques F Meis, Pr Stephane Ranque

  86. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia

    Article • Journal of Infection, October 2016, Elsevier

    Armindo Perozo-Mena, Dr Jacques F Meis

  87. Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus Strains

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Dr Hamid Badali, KOICHI MAKIMURA, mahdi abastabar, Dr Jacques F Meis

  88. Intra- and Interlaboratory Agreement in Assessing theIn VitroActivity of Micafungin against Common and Rare Candida Species with the EUCAST, CLSI, and Etest Methods

    Article • Antimicrobial Agents and Chemotherapy, August 2016, ASM Journals

    Dr Jacques F Meis

  89. Azole resistance surveillance inAspergillus fumigatus: beneficial or biased?

    Article • Journal of Antimicrobial Chemotherapy, July 2016, Oxford University Press (OUP)

    Dr Jacques F Meis

  90. Identification by Molecular Methods and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and Antifungal Susceptibility Profiles of Clinically Significant Rare Aspergillus Species in a Referral Chest Hospital in Delhi, India

    Article • Journal of Clinical Microbiology, July 2016, ASM Journals

    Dr Jacques F Meis

  91. Non-traumatic keratitis due to Colletotrichum truncatum

    Article • JMM Case Reports, July 2016, Society for General Microbiology

    Dr Jacques F Meis

  92. Identification and typing of the emerging pathogenCandida aurisby matrix-assisted laser desorption ionisation time of flight mass spectrometry

    Article • Mycoses, June 2016, Wiley

    Dr Jacques F Meis

  93. Cryptococcus tetragattii as a major cause of cryptococcal meningitis among HIV-infected individuals in Harare, Zimbabwe

    Article • Journal of Infection, June 2016, Elsevier

    Dr Jacques F Meis

  94. Bacteroides fragilis in biopsies of patients with major abscesses and diabetic foot infections: direct molecular versus culture-based detection

    Article • Diagnostic Microbiology and Infectious Disease, June 2016, Elsevier

    Dr Jacques F Meis

  95. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses

    Article • Emerging Microbes & Infections, May 2016, Springer Science + Business Media

    Dr Jacques F Meis

  96. Filamentous Fungi in Respiratory Infections. What Lies Beyond Aspergillosis and Mucormycosis?

    Article • PLoS Pathogens, April 2016, PLOS

    Dr Jacques F Meis

  97. Are the TR46/Y121F/T289A Mutations in Azole-Resistant Aspergillosis Patient Acquired or Environmental?

    Article • Antimicrobial Agents and Chemotherapy, April 2016, ASM Journals

    Dr Jacques F Meis

  98. Molecular epidemiology andin vitroantifungal susceptibility testing of 108 clinicalCryptococcus neoformans sensu latoandCryptococcus gattii sensu latoisolates from Denmark

    Article • Mycoses, April 2016, Wiley

    Dr Jacques F Meis

  99. Fusarium: Molecular Diversity and Intrinsic Drug Resistance

    Article • PLoS Pathogens, April 2016, PLOS

    Dr Jacques F Meis

  100. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism

    Article • Clinical Microbiology and Infection, March 2016, Elsevier

    Dr Jacques F Meis

  101. Geographically predominant genotypes of Aspergillus terreus species complex in Austria: s microsatellite typing study

    Article • Clinical Microbiology and Infection, March 2016, Elsevier

    Dr Jacques F Meis

  102. Fusarium ramigenum, a novel human opportunist in a patient with common variable immunodeficiency and cellular immune defects: case report

    Article • BMC Infectious Diseases, February 2016, Springer Science + Business Media

    Dr Jacques F Meis

  103. DNA barcoding, MALDI-TOF, and AFLP data support Fusarium ficicrescens as a distinct species within the Fusarium fujikuroi species complex

    Article • Fungal Biology, February 2016, Elsevier

    Dr Jacques F Meis

  104. Genotyping of clinical and environmentalAspergillus flavusisolates from Iran using microsatellites

    Article • Mycoses, January 2016, Wiley

    Dr Jacques F Meis, Dr Hamid Badali

  105. Discovery of a sexual cycle in Talaromyces amestolkiae

    Article • Mycologia, January 2016, Taylor & Francis

    Dr Jacques F Meis

  106. In vitrocombinations of natamycin with voriconazole, itraconazole and micafungin against clinicalFusariumstrains causing keratitis: Table 1.

    Article • Journal of Antimicrobial Chemotherapy, December 2015, Oxford University Press (OUP)

    Dr Jacques F Meis

  107. Comparison of biotyping methods as alternative identification tools to molecular typing of pathogenicCryptococcusspecies in sub-Saharan Africa

    Article • Mycoses, December 2015, Wiley

    Mr Tinashe K Nyazika, Dr Jacques F Meis

  108. Diagnosis and management of aspergillosis in the Netherlands: a national survey

    Article • Mycoses, December 2015, Wiley

    Dr Jacques F Meis

  109. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method

    Article • Antimicrobial Agents and Chemotherapy, December 2015, ASM Journals

    Dr Jacques F Meis

  110. Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis

    Article • PLoS ONE, November 2015, PLOS

    Dr Jacques F Meis, Dr. Mohammad Asadzadeh

  111. The post-vaccine microevolution of invasive Streptococcus pneumoniae

    Article • Scientific Reports, October 2015, Springer Science + Business Media

    Dr Jacques F Meis

  112. Azole Resistance inAspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

    Article • Clinical Infectious Diseases, October 2015, Oxford University Press (OUP)

    Dr Jacques F Meis

  113. Cryptococcal meningitis due toCryptococcus neoformansgenotype AFLP1/VNI in Iran: a review of the literature

    Article • Mycoses, October 2015, Wiley

    Dr Jacques F Meis, Dr Hamid Badali

  114. Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species

    Article • Antimicrobial Agents and Chemotherapy, October 2015, ASM Journals

    Dr Jacques F Meis

  115. Treatment of prosthetic joint infections due toPropionibacterium

    Article • Acta Orthopaedica, September 2015, Taylor & Francis

    Dr Jacques F Meis

  116. In VitroSusceptibility Profiles of Eight Antifungal Drugs against Clinical and Environmental Strains of Phaeoacremonium

    Article • Antimicrobial Agents and Chemotherapy, September 2015, ASM Journals

    Dr Jacques F Meis, Dr Hamid Badali

  117. Candida parapsilosis Resistance to Fluconazole: Molecular Mechanisms andIn VivoImpact in Infected Galleria mellonella Larvae

    Article • Antimicrobial Agents and Chemotherapy, August 2015, ASM Journals

    Dr Jacques F Meis

  118. In VitroActivities of Eight Antifungal Drugs against a Global Collection of Genotyped Exserohilum Isolates

    Article • Antimicrobial Agents and Chemotherapy, August 2015, ASM Journals

    Dr Jacques F Meis

  119. A Novel Y319H Substitution in CYP51C Associated with Azole Resistance in Aspergillus flavus

    Article • Antimicrobial Agents and Chemotherapy, July 2015, ASM Journals

    Arunaloke Chakrabarti, Dr Jacques F Meis

  120. Draft Genome Sequence of a Fluconazole-Resistant Candida auris Strain from a Candidemia Patient in India

    Article • Genome Announcements, July 2015, ASM Journals

    Dr Jacques F Meis

  121. Erratum for Abdolrasouli et al., Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing

    Article • mBio, July 2015, ASM Journals

    Professor Matthew C Fisher, Dr Jacques F Meis

  122. High prevalence of azole resistance inAspergillus fumigatusisolates from high-risk patients

    Article • Journal of Antimicrobial Chemotherapy, July 2015, Oxford University Press (OUP)

    Dr Jacques F Meis

  123. Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infections

    Article • European Journal of Clinical Microbiology & Infectious Diseases, July 2015, Springer Science + Business Media

    Dr Jacques F Meis

  124. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus

    Article • Drug Resistance Updates, July 2015, Elsevier

    Dr Seyedmojtaba Seyedmousavi, Dr Jacques F Meis

  125. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 – 2015

    Article • BMC Microbiology, June 2015, Springer Science + Business Media

    Dr Jacques F Meis

  126. Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing

    Article • mBio, June 2015, ASM Journals

    Professor Matthew C Fisher, Dr Jacques F Meis

  127. Triazole-resistant Aspergillus fumigatus harbouring G54 mutation: Is it de novo or environmentally acquired?

    Article • Journal of Global Antimicrobial Resistance, June 2015, Elsevier

    Dr Jacques F Meis

  128. Cryptococcus gattii genotype AFLP6/VGII meningoencephalitis in an immunocompetent Filipino male in Kuwait: activation of a dormant infection

    Article • JMM Case Reports, June 2015, Society for General Microbiology

    Dr Jacques F Meis

  129. Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis

    Article • PLoS Pathogens, May 2015, PLOS

    Dr Jacques F Meis

  130. Hip and knee arthroplasty: quo vadis?

    Article • Antimicrobial Resistance and Infection Control, May 2015, Springer Science + Business Media

    Dr Jacques F Meis

  131. Proximal subungual onychomycosis caused byFusarium falciformesuccessfully cured with posaconazole

    Article • British Journal of Dermatology, May 2015, Oxford University Press (OUP)

    Dr Jacques F Meis, Professor Alexandro Bonifaz

  132. Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia

    Article • Frontiers in Microbiology, May 2015, Frontiers

    Dr Jacques F Meis

  133. Debridement, antibiotics and implant retention in early postoperative infection with Enterococcus sp.

    Article • Clinical Microbiology and Infection, May 2015, Elsevier

    Dr Jacques F Meis

  134. First Description of Azole-Resistant Aspergillus fumigatus Due to TR46/Y121F/T289A Mutation in France

    Article • Antimicrobial Agents and Chemotherapy, April 2015, ASM Journals

    Dr Jacques F Meis

  135. Multi-triazole-resistantAspergillus fumigatusinfections in Australia

    Article • Mycoses, April 2015, Wiley

    Dr Jacques F Meis

  136. Infections caused by rare fungi

    Article • Journal of Microbiology Immunology and Infection, April 2015, Elsevier

    Dr Jacques F Meis

  137. Emergence of azole resistant Aspergillus in hospitals and role of the environment. Only a European problem or is Asia next?

    Article • Journal of Microbiology Immunology and Infection, April 2015, Elsevier

    Dr Jacques F Meis

  138. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2,...

    Article • Journal of Clinical Microbiology, March 2015, ASM Journals

    Dr Jacques F Meis

  139. Molecular Epidemiology and In-Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Isolates in Delhi, India: Evidence of Genetic Diversity by Amplified Fragment Length Polymorphism and Microsatellite Typing

    Article • PLoS ONE, March 2015, PLOS

    Dr Jacques F Meis

  140. In vitrosusceptibility patterns of clinically importantTrichophytonandEpidermophytonspecies against nine antifungal drugs

    Article • Mycoses, March 2015, Wiley

    Dr Rasoul Mohammadi, Dr Jacques F Meis, Dr Hamid Badali

  141. Pharmacodynamics of Isavuconazole in an Aspergillus fumigatus Mouse Infection Model

    Article • Antimicrobial Agents and Chemotherapy, March 2015, ASM Journals

    Professor Johan w mouton, Dr Seyedmojtaba Seyedmousavi, Dr Jacques F Meis

  142. Debridement, antibiotics and implant retention in early postoperative infection with Pseudomonas aeruginosa

    Article • Journal of Infection, March 2015, Elsevier

    Dr Jacques F Meis

  143. Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples

    Article • BMC Infectious Diseases, February 2015, Springer Science + Business Media

    Dr Jacques F Meis

  144. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

    Article • Journal of Antimicrobial Chemotherapy, January 2015, Oxford University Press (OUP)

    Dr Jacques F Meis

  145. Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales

    Article • Antimicrobial Agents and Chemotherapy, January 2015, ASM Journals

    Dr Jacques F Meis, Dr Eric Dannaoui

  146. Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006–2008)

    Article • Clinical Microbiology and Infection, January 2015, Elsevier

    Dr Jacques F Meis

  147. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex

    Article • Journal of Antimicrobial Chemotherapy, December 2014, Oxford University Press (OUP)

    Dr Jacques F Meis

  148. Cryptococcus and Cryptococcosis in Cuba. A minireview

    Article • Mycoses, November 2014, Wiley

    Dr Jacques F Meis

  149. Keratitis by Fusarium temperatum, a novel opportunist

    Article • BMC Infectious Diseases, November 2014, Springer Science + Business Media

    Dr Jacques F Meis

  150. Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures

    Article • Journal of Antimicrobial Chemotherapy, October 2014, Oxford University Press (OUP)

    Dr Jacques F Meis, Professor Suhail Ahmad

  151. Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for the Cryptococcus neoformans-Cryptococcus gattii Species Complex Using the CLSI M27-A3 Broth Microdilution Method

    Article • Antimicrobial Agents and Chemotherapy, October 2014, ASM Journals

    Dr Jacques F Meis

  152. Name Changes in Medically Important Fungi and Their Implications for Clinical Practice

    Article • Journal of Clinical Microbiology, October 2014, ASM Journals

    Dr Jacques F Meis

  153. Species boundaries and nomenclature of Rhizopus arrhizus (syn. R. oryzae)

    Article • Mycoses, September 2014, Wiley

    Dr Jacques F Meis

  154. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India

    Article • Mycoses, September 2014, Wiley

    Dr Jacques F Meis

  155. Fatal Disseminated Infection with Fusarium petroliphilum

    Article • Mycopathologia, September 2014, Springer Science + Business Media

    Dr Jacques F Meis

  156. Roussoella percutanea, a novel opportunistic pathogen causing subcutaneous mycoses

    Article • Medical Mycology, September 2014, Oxford University Press (OUP)

    Dr Jacques F Meis

  157. Recognizing filamentous basidiomycetes as agents of human disease: A review

    Article • Medical Mycology, September 2014, Oxford University Press (OUP)

    Dr Jacques F Meis

  158. Passive Surveillance for Azole-ResistantAspergillus fumigatus, United States, 2011–2013

    Article • Emerging Infectious Diseases, September 2014, Centers for Disease Control and Prevention (CDC)

    Dr Jacques F Meis

  159. Invasive Mycosis Due to Species of Blastobotrys in Immunocompromised Patients with Reduced Susceptibility to Antifungals

    Article • Journal of Clinical Microbiology, August 2014, ASM Journals

    Dr Jacques F Meis

  160. Voriconazole-Resistant Penicillium oxalicum: An Emerging Pathogen in Immunocompromised Hosts

    Article • Open Forum Infectious Diseases, August 2014, Oxford University Press (OUP)

    Dr Jacques F Meis

  161. Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait

    Article • Environmental Research, August 2014, Elsevier

    Dr Jacques F Meis, Professor Suhail Ahmad

  162. Susceptibility and Diversity in the Therapy-Refractory Genus Scedosporium

    Article • Antimicrobial Agents and Chemotherapy, July 2014, ASM Journals

    Dr Jacques F Meis

  163. In VitroActivities of Eight Antifungal Drugs against 104 Environmental and Clinical Isolates of Aureobasidium pullulans

    Article • Antimicrobial Agents and Chemotherapy, July 2014, ASM Journals

    Dr Jacques F Meis, Dr. Hossein Zarrinfar

  164. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania

    Article • Journal of Antimicrobial Chemotherapy, July 2014, Oxford University Press (OUP)

    Dr Jacques F Meis

  165. Molecular characterization of Cryptococcus gattii genotype AFLP6/VGII isolated from woody debris of divi-divi (Caesalpinia coriaria), Bonaire, Dutch Caribbean

    Article • Revista Iberoamericana de Micología, July 2014, Elsevier

    Dr Jacques F Meis

  166. Proposed nomenclature for Pseudallescheria, Scedosporium and related genera

    Article • Fungal Diversity, July 2014, Springer Science + Business Media

    Dr Jacques F Meis

  167. In VitroAntifungal Susceptibility Profile and Correlation of Mycelial and Yeast Forms of Molecularly Characterized Histoplasma capsulatum Strains from India

    Article • Antimicrobial Agents and Chemotherapy, June 2014, ASM Journals

    Dr Jacques F Meis

  168. Uncommon opportunistic yeast bloodstream infections from Qatar

    Article • Medical Mycology, June 2014, Oxford University Press (OUP)

    Dr Saad J. Taj-Aldeen, Dr Jacques F Meis

  169. Interlaboratory Comparison of Sample Preparation Methods, Database Expansions, and Cutoff Values for Identification of Yeasts by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Using a Yeast Test Panel

    Article • Journal of Clinical Microbiology, June 2014, ASM Journals

    Dr Teun Boekhout, Dr Jacques F Meis

  170. Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia

    Article • Vaccine, June 2014, Elsevier

    Dr Jacques F Meis

  171. Exploring azole antifungal drug resistance inAspergillus fumigatuswith special reference to resistance mechanisms

    Article • Future Microbiology, May 2014, Future Medicine

    Dr Jacques F Meis

  172. Validation of a novel real-time PCR for detecting Rasamsonia argillacea species complex in respiratory secretions from cystic fibrosis patients

    Article • New Microbes and New Infections, May 2014, Elsevier

    Dr Jacques F Meis

  173. Avidity of Antibodies against Infecting Pneumococcal Serotypes Increases with Age and Severity of Disease

    Article • Clinical and Vaccine Immunology, April 2014, ASM Journals

    Dr Jacques F Meis

  174. Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia

    Article • Journal of Antimicrobial Chemotherapy, April 2014, Oxford University Press (OUP)

    Dr Jacques F Meis

  175. Simple, Low-Cost Molecular Assays for TR34/L98H Mutations in the cyp51A Gene for Rapid Detection of Triazole-Resistant Aspergillus fumigatus Isolates

    Article • Journal of Clinical Microbiology, April 2014, ASM Journals

    Dr Jacques F Meis, Professor Suhail Ahmad

  176. Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India

    Article • Mycoses, April 2014, Wiley

    Dr Jacques F Meis

  177. Different colonization patterns of Aspergillus terreus in patients with cystic fibrosis

    Article • Clinical Microbiology and Infection, April 2014, Elsevier

    Dr Jacques F Meis

  178. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases

    Article • Clinical Microbiology and Infection, April 2014, Elsevier

    Dr Jacques F Meis

  179. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

    Article • Clinical Microbiology and Infection, April 2014, Elsevier

    Dr Jacques F Meis, Dr Eric Dannaoui

  180. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

    Article • Clinical Microbiology and Infection, April 2014, Elsevier

    Dr Eric Dannaoui, Dr Jacques F Meis

  181. ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

    Article • Clinical Microbiology and Infection, April 2014, Elsevier

    Dr Eric Dannaoui, Dr Jacques F Meis

  182. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi

    Article • Clinical Microbiology and Infection, April 2014, Elsevier

    Dr Eric Dannaoui, Dr Jacques F Meis

  183. Diagnostic value of serum pneumococcal DNA load during invasive pneumococcal infections

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 2014, Springer Science + Business Media

    Dr Jacques F Meis

  184. Molecular epidemiology and antifungal susceptibility of Serbian Cryptococcus neoformans isolates

    Article • Mycoses, January 2014, Wiley

    Dr Jacques F Meis

  185. Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

    Article • Antimicrobial Agents and Chemotherapy, January 2014, ASM Journals

    Dr Jacques F Meis

  186. Multidrug-resistant endemic clonal strain of Candida auris in India

    Article • European Journal of Clinical Microbiology & Infectious Diseases, December 2013, Springer Science + Business Media

    Dr Jacques F Meis

  187. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern

    Article • Infection, December 2013, Springer Science + Business Media

    Dr Jacques F Meis, Dr Saad J. Taj-Aldeen, Dr Saad J. Taj-Aldeen

  188. Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method

    Article • Antimicrobial Agents and Chemotherapy, November 2013, ASM Journals

    Dr Jacques F Meis

  189. Correction: Emergence of Azole-Resistant Aspergillus fumigatus Strains due to Agricultural Azole Use Creates an Increasing Threat to Human Health

    Article • PLoS Pathogens, November 2013, PLOS

    Dr Jacques F Meis

  190. Emergence of Azole-Resistant Aspergillus fumigatus Strains due to Agricultural Azole Use Creates an Increasing Threat to Human Health

    Article • PLoS Pathogens, October 2013, PLOS

    Dr Jacques F Meis

  191. Reply to “Implications of High Antifungal Susceptibility on Schizophyllum commune-Associated Allergy in Clinical Practice”

    Article • Antimicrobial Agents and Chemotherapy, October 2013, ASM Journals

    Dr Jacques F Meis

  192. In VitroActivities of Eight Antifungal Drugs against 106 Waterborne and Cutaneous Exophiala Species

    Article • Antimicrobial Agents and Chemotherapy, October 2013, ASM Journals

    Dr Jacques F Meis

  193. New Clonal Strain ofCandida auris, Delhi, India

    Article • Emerging Infectious Diseases, October 2013, Centers for Disease Control and Prevention (CDC)

    Dr Jacques F Meis

  194. New Clonal Strain ofCandida auris, Delhi, India

    Article • Emerging Infectious Diseases, October 2013, Centers for Disease Control and Prevention (CDC)

    Dr Jacques F Meis

  195. Azole-resistant Aspergillus fumigatus with the environmental TR46/Y121F/T289A mutation in India

    Article • Journal of Antimicrobial Chemotherapy, October 2013, Oxford University Press (OUP)

    Dr Jacques F Meis

  196. Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

    Article • Antimicrobial Agents and Chemotherapy, September 2013, ASM Journals

    Dr Jacques F Meis, Dr Eric Dannaoui

  197. Geographically Structured Populations of Cryptococcus neoformans Variety grubii in Asia Correlate with HIV Status and Show a Clonal Population Structure

    Article • PLoS ONE, September 2013, PLOS

    Dr Jacques F Meis, Dr Saad J. Taj-Aldeen, Professor Matthew C Fisher

  198. Genotypic diversity of Pseudomonas aeruginosa in cystic fibrosis siblings in Qatar using AFLP fingerprinting

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 2013, Springer Science + Business Media

    Dr Jacques F Meis, Dr Saad J. Taj-Aldeen, Dr Saad J. Taj-Aldeen, Dr Ammar Saadoon Alishlash

  199. Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser

    Article • Journal of Medical Microbiology, August 2013, Society for General Microbiology

    Dr Jacques F Meis, Dr Hamid Badali

  200. Microcalorimetry Assay for Rapid Detection of Voriconazole Resistance in Aspergillus fumigatus

    Article • Antimicrobial Agents and Chemotherapy, August 2013, ASM Journals

    Dr Jacques F Meis

  201. Ancient Dispersal of the Human Fungal Pathogen Cryptococcus gattii from the Amazon Rainforest

    Article • PLoS ONE, August 2013, PLOS

    Dr Jacques F Meis, Dr Kerstin Voelz

  202. Clinical Significance and Molecular Characterization of Nonsporulating Molds Isolated from the Respiratory Tracts of Bronchopulmonary Mycosis Patients with Special Reference to Basidiomycetes

    Article • Journal of Clinical Microbiology, July 2013, ASM Journals

    Dr Jacques F Meis

  203. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

    Article • Clinical & Experimental Allergy, July 2013, Wiley

    Dr Jacques F Meis, Professor Richard B Moss

  204. First neonatal case of fungaemia due to Pseudozyma aphidis and a global literature review

    Article • Mycoses, July 2013, Wiley

    Dr Jacques F Meis

  205. Taxonomy and epidemiology of Mucor irregularis , agent of chronic cutaneous mucormycosis

    Article • Persoonia - Molecular Phylogeny and Evolution of Fungi, June 2013, Naturalis Biodiversity Center

    Dr Jacques F Meis

  206. Photodynamic fungicidal efficacy of hypericin and dimethyl methylene blue against azole‐resistant Candida albicans strains

    Article • Mycoses, June 2013, Wiley

    Dr Jacques F Meis

  207. Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method

    Article • Antimicrobial Agents and Chemotherapy, May 2013, ASM Journals

    Dr Jacques F Meis

  208. Environmental study of azole‐resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran

    Article • Mycoses, May 2013, Wiley

    Dr Jacques F Meis, Dr Hamid Badali

  209. Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India

    Article • Diagnostic Microbiology and Infectious Disease, May 2013, Elsevier

    Dr Jacques F Meis

  210. Microbial profiling does not differentiate between childhood recurrent acute otitis media and chronic otitis media with effusion

    Article • International Journal of Pediatric Otorhinolaryngology, April 2013, Elsevier

    Dr Jacques F Meis, J HAYS

  211. Molecular Characterization andIn VitroAntifungal Susceptibility Profile of Schizophyllum commune, an Emerging Basidiomycete in Bronchopulmonary Mycoses

    Article • Antimicrobial Agents and Chemotherapy, March 2013, ASM Journals

    Dr Jacques F Meis

  212. Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba

    Article • Mycopathologia, March 2013, Springer Science + Business Media

    Dr Jacques F Meis, Dr Hamid Badali

  213. Severe Disseminated Phaeohyphomycosis in an Immunocompetent Patient Caused by Veronaea botryosa

    Article • Mycopathologia, March 2013, Springer Science + Business Media

    Dr Jacques F Meis, Dr Hamid Badali

  214. Veronaea botryosa: Molecular Identification with Amplified Fragment Length Polymorphism (AFLP) and In vitro Antifungal Susceptibility

    Article • Mycopathologia, March 2013, Springer Science + Business Media

    Dr Jacques F Meis, Dr Hamid Badali

  215. Subcutaneous phaeohyphomycosis caused by Exophiala equina, with susceptibility to eight antifungal drugs

    Article • Journal of Medical Microbiology, February 2013, Society for General Microbiology

    Dr Jacques F Meis

  216. Allergic bronchopulmonary mycosis due to fungi other thanAspergillus: a global overview

    Article • Critical Reviews in Microbiology, February 2013, Taylor & Francis

    Dr Jacques F Meis

  217. In VitroAntifungal Susceptibility of Cladophialophora carrionii, an Agent of Human Chromoblastomycosis

    Article • Antimicrobial Agents and Chemotherapy, February 2013, ASM Journals

    Dr Jacques F Meis, Dr Hamid Badali

  218. Cryptococcus gattii Induces a Cytokine Pattern That Is Distinct from Other Cryptococcal Species

    Article • PLoS ONE, January 2013, PLOS

    Dr Jacques F Meis

  219. First environmental isolation of Cryptococcus gattii, genotype AFLP5, from India and a global review

    Article • Mycoses, January 2013, Wiley

    Dr Jacques F Meis

  220. Identification and Typing of Isolates of Cyphellophora and Relatives by Use of Amplified Fragment Length Polymorphism and Rolling Circle Amplification

    Article • Journal of Clinical Microbiology, January 2013, ASM Journals

    Dr Jacques F Meis

  221. Fatal Cryptococcus gattii genotype AFLP5 infection in an immunocompetent Cuban patient

    Article • Medical Mycology Case Reports, January 2013, Elsevier

    Dr Jacques F Meis

  222. Molecular Identification and Susceptibility Pattern of ClinicalNocardiaSpecies: Emergence ofNocardia crassostreaeas an Agent of Invasive Nocardiosis

    Article • Canadian Journal of Infectious Diseases and Medical Microbiology, January 2013, Hindawi Publishing Corporation

    Dr Saad J. Taj-Aldeen, Dr Jacques F Meis

  223. Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India

    Article • PLoS ONE, December 2012, PLOS

    Dr Jacques F Meis

  224. Clinical Significance of Filamentous Basidiomycetes Illustrated by Isolates of the Novel Opportunist Ceriporia lacerata from the Human Respiratory Tract

    Article • Journal of Clinical Microbiology, December 2012, ASM Journals

    Dr Jacques F Meis

  225. A rare case of allergic bronchopulmonary mycosis caused byAlternaria alternata

    Article • Medical Mycology, November 2012, Oxford University Press (OUP)

    Dr Jacques F Meis

  226. Taxonomy and Antifungal Susceptibility of Clinically Important Rasamsonia Species

    Article • Journal of Clinical Microbiology, October 2012, ASM Journals

    Dr Jacques F Meis

  227. Autochthonous and DormantCryptococcus gattiiInfections in Europe

    Article • Emerging Infectious Diseases, October 2012, Centers for Disease Control and Prevention (CDC)

    Dr Jacques F Meis

  228. In VitroAntifungal Activity of Isavuconazole against Madurella mycetomatis

    Article • Antimicrobial Agents and Chemotherapy, September 2012, ASM Journals

    Dr Jacques F Meis

  229. In VitroActivities of Nine Antifungal Drugs against 81 Phialophora and Cyphellophora Isolates

    Article • Antimicrobial Agents and Chemotherapy, September 2012, ASM Journals

    Dr Jacques F Meis

  230. Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

    Article • Antimicrobial Agents and Chemotherapy, September 2012, ASM Journals

    Dr Jacques F Meis

  231. First Human Case of Pulmonary Fungal Ball Due to a Perenniporia Species (a Basidiomycete)

    Article • Journal of Clinical Microbiology, August 2012, ASM Journals

    Dr Jacques F Meis

  232. Microsatellite Genotyping Clarified Conspicuous Accumulation of Candida parapsilosis at a Cardiothoracic Surgery Intensive Care Unit

    Article • Journal of Clinical Microbiology, August 2012, ASM Journals

    Dr Jacques F Meis

  233. Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp.

    Article • Diagnostic Microbiology and Infectious Disease, August 2012, Elsevier

    Dr Jacques F Meis

  234. Black yeast-like fungi associated with Lethargic Crab Disease (LCD) in the mangrove-land crab, Ucides cordatus (Ocypodidae)

    Article • Veterinary Microbiology, July 2012, Elsevier

    Dr Jacques F Meis

  235. Molecular identification tools for sibling species of Scedosporium and Pseudallescheria

    Article • Medical Mycology, July 2012, Oxford University Press (OUP)

    Dr Jacques F Meis

  236. Isothermal microcalorimetry: a novel method for real-time determination of antifungal susceptibility of Aspergillus species

    Article • Clinical Microbiology and Infection, July 2012, Elsevier

    Dr Jacques F Meis

  237. Molecular Epidemiology of Aspergillus fumigatus Isolates Harboring the TR34/L98H Azole Resistance Mechanism

    Article • Journal of Clinical Microbiology, June 2012, ASM Journals

    Dr Jacques F Meis

  238. Bis(methyl)gliotoxin proves to be a more stable and reliable marker for invasive aspergillosis than gliotoxin and suitable for use in diagnosis

    Article • Diagnostic Microbiology and Infectious Disease, May 2012, Elsevier

    Dr Jacques F Meis

  239. Schizophyllum commune as an emerging fungal pathogen: a review and report of two cases

    Article • Mycoses, April 2012, Wiley

    Dr Jacques F Meis

  240. Extensive Genetic Diversity within the Dutch Clinical Cryptococcus neoformans Population

    Article • Journal of Clinical Microbiology, March 2012, ASM Journals

    Dr Jacques F Meis

  241. Rapid Susceptibility Testing and Microcolony Analysis of Candida spp. Cultured and Imaged on Porous Aluminum Oxide

    Article • PLoS ONE, March 2012, PLOS

    Dr Jacques F Meis

  242. Resistance of Asian Cryptococcus neoformans Serotype A Is Confined to Few Microsatellite Genotypes

    Article • PLoS ONE, March 2012, PLOS

    Dr Jacques F Meis, Dr Saad J. Taj-Aldeen, Dr Saad J. Taj-Aldeen

  243. Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Amphotericin B and Flucytosine

    Article • Antimicrobial Agents and Chemotherapy, March 2012, ASM Journals

    Dr Jacques F Meis

  244. Environmental isolation and characterisation of Cryptococcus species from living trees in Havana city, Cuba

    Article • Mycoses, February 2012, Wiley

    Dr Jacques F Meis

  245. Multiple subcutaneous cysts due toExophiala spiniferain an immunocompetent patient

    Article • Medical Mycology, February 2012, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Seyedmojtaba Seyedmousavi, Dr Hamid Badali

  246. Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species

    Article • Antimicrobial Agents and Chemotherapy, January 2012, ASM Journals

    Dr Jacques F Meis

  247. Temperate Climate Niche forCryptococcus gattiiin Northern Europe

    Article • Emerging Infectious Diseases, January 2012, Centers for Disease Control and Prevention (CDC)

    Dr Jacques F Meis

  248. USA300 Methicillin-resistant Staphylococcus aureus in Cuba

    Article • Antimicrobial Resistance and Infection Control, January 2012, Springer Science + Business Media

    Dr Jacques F Meis

  249. Environmental prevalence ofCryptococcus neoformansandCryptococcus gattiiin India: An update

    Article • Critical Reviews in Microbiology, December 2011, Taylor & Francis

    Dr Jacques F Meis

  250. In vitro activity of isavuconazole against 208 Aspergillus flavus isolates in comparison with 7 other antifungal agents: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing

    Article • Diagnostic Microbiology and Infectious Disease, December 2011, Elsevier

    Dr Jacques F Meis

  251. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

    Article • Clinical Microbiology and Infection, December 2011, Elsevier

    Dr Jacques F Meis

  252. High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole

    Article • Antimicrobial Agents and Chemotherapy, November 2011, ASM Journals

    Dr Jacques F Meis

  253. Evidence for genetic differentiation and variable recombination rates among Dutch populations of the opportunistic human pathogen Aspergillus fumigatus

    Article • Molecular Ecology, November 2011, Wiley

    Dr Jacques F Meis, Professor Antonis Rokas

  254. Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales

    Article • Journal of Clinical Microbiology, November 2011, ASM Journals

    Dr Jacques F Meis, Dr Eric Dannaoui

  255. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist

    Article • Medical Mycology, November 2011, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Hamid Badali

  256. Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India

    Article • Journal of Antimicrobial Chemotherapy, October 2011, Oxford University Press (OUP)

    Dr Jacques F Meis

  257. Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons

    Article • Fungal Biology, October 2011, Elsevier

    Dr Jacques F Meis, Dr Hamid Badali

  258. Fonsecaea multimorphosa sp. nov, a new species of Chaetothyriales isolated from a feline cerebral abscess

    Article • Fungal Biology, October 2011, Elsevier

    Dr Jacques F Meis

  259. Severe prosthetic joint infection in an immunocompetent male patient due to a therapy refractory Pseudallescheria apiosperma

    Article • Mycoses, October 2011, Wiley

    Dr Jacques F Meis

  260. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates

    Article • Mycoses, October 2011, Wiley

    Dr Jacques F Meis

  261. European expert opinion on the management of invasive candidiasis in adults

    Article • Clinical Microbiology and Infection, September 2011, Elsevier

    Dr Jacques F Meis

  262. Molecular Epidemiology of Aspergillus fumigatus: an In-Depth Genotypic Analysis of Isolates Involved in an Outbreak of Invasive Aspergillosis

    Article • Journal of Clinical Microbiology, August 2011, ASM Journals

    Dr Jacques F Meis

  263. Meningitis caused by Filobasidium uniguttulatum: case report and overview of the literature

    Article • Mycoses, July 2011, Wiley

    Dr Jacques F Meis

  264. Methicillin-resistant Staphylococcus aureus without borders: USA300 in Cuba

    Article • BMC Proceedings, June 2011, Springer Science + Business Media

    Dr Jacques F Meis

  265. Reactivation of a Cryptococcus gattii infection in a cheetah (Acinonyx jubatus) held in the National Zoo, Havana, Cuba

    Article • Mycoses, June 2011, Wiley

    Dr Jacques F Meis

  266. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs

    Article • Mycoses, April 2011, Wiley

    Dr Jacques F Meis

  267. Fatal Cerebral Phaeohyphomycosis in an Immunocompetent Individual Due to Thielavia subthermophila

    Article • Journal of Clinical Microbiology, March 2011, ASM Journals

    Dr Jacques F Meis, Dr Hamid Badali

  268. High Resolution Genotyping of Clinical Aspergillus flavus Isolates from India Using Microsatellites

    Article • PLoS ONE, January 2011, PLOS

    Dr Jacques F Meis

  269. Microsatellite typing and susceptibilities of serial Cryptococcus neoformansisolates from Cuban patients with recurrent cryptococcal meningitis

    Article • BMC Infectious Diseases, October 2010, Springer Science + Business Media

    Dr Jacques F Meis

  270. Apophysomyces elegans: Epidemiology, Amplified Fragment Length Polymorphism Typing, andIn VitroAntifungal Susceptibility Pattern

    Article • Journal of Clinical Microbiology, September 2010, ASM Journals

    Dr Jacques F Meis

  271. In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates

    Article • Antimicrobial Agents and Chemotherapy, September 2010, ASM Journals

    Dr Jacques F Meis

  272. Subcutaneous phaeohyphomycotic cyst caused by Pyrenochaeta romeroi

    Article • Medical Mycology, August 2010, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Hamid Badali

  273. Rhinocladiella aquaspersa , proven agent of verrucous skin infection and a novel type of chromoblastomycosis

    Article • Medical Mycology, August 2010, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Hamid Badali

  274. Use of Amplified Fragment Length Polymorphism To Identify 42 Cladophialophora Strains Related to Cerebral Phaeohyphomycosis with In Vitro Antifungal Susceptibility

    Article • Journal of Clinical Microbiology, April 2010, ASM Journals

    Dr Jacques F Meis, Dr Hamid Badali

  275. The clinical spectrum of Exophiala jeanselmei , with a case report and in vitro antifungal susceptibility of the species

    Article • Medical Mycology, March 2010, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Hamid Badali

  276. Novel mixed-format real-time PCR assay to detect mutations conferring resistance to triazoles in Aspergillus fumigatus and prevalence of multi-triazole resistance among clinical isolates in the Netherlands

    Article • Journal of Antimicrobial Chemotherapy, February 2010, Oxford University Press (OUP)

    Dr Jacques F Meis

  277. Microsatellite Typing of Clinical and Environmental Cryptococcus neoformans var. grubii Isolates from Cuba Shows Multiple Genetic Lineages

    Article • PLoS ONE, February 2010, PLOS

    Dr Jacques F Meis

  278. In Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp.

    Article • Antimicrobial Agents and Chemotherapy, January 2010, ASM Journals

    Dr Jacques F Meis, Dr Hamid Badali

  279. First Autochthonous Case of Rhinocladiella mackenziei Cerebral Abscess Outside the Middle East

    Article • Journal of Clinical Microbiology, December 2009, ASM Journals

    Dr Jacques F Meis, Dr Hamid Badali

  280. Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis

    Article • Medical Mycology, December 2009, Oxford University Press (OUP)

    Dr Jacques F Meis

  281. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection

    Article • Journal of Antimicrobial Chemotherapy, October 2009, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Hamid Badali

  282. Utility of CSP typing to sub-type clinical Aspergillus fumigatus isolates and proposal for a new CSP type nomenclature

    Article • Journal of Microbiological Methods, June 2009, Elsevier

    Dr Jacques F Meis

  283. Moulds and man

    Article • Journal of Antimicrobial Chemotherapy, May 2009, Oxford University Press (OUP)

    Dr Jacques F Meis

  284. Neuroborreliose bij kinderen, herkenning en diagnostiek

    Article • Tijdschrift voor kindergeneeskunde, April 2009, Springer Science + Business Media

    Dr Jacques F Meis

  285. In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species

    Article • Journal of Antimicrobial Chemotherapy, March 2009, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Hamid Badali

  286. Molecular Identification and Susceptibility of Trichosporon Species Isolated from Clinical Specimens in Qatar: Isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov.

    Article • Journal of Clinical Microbiology, March 2009, ASM Journals

    Dr Jacques F Meis, Dr Saad J. Taj-Aldeen, Dr Saad J. Taj-Aldeen

  287. Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis

    Article • Journal of Cystic Fibrosis, March 2009, Elsevier

    Dr Jacques F Meis

  288. Interlaboratory reproducibility of a microsatellite-based typing assay for Aspergillus fumigatus through the use of allelic ladders: proof of concept

    Article • Clinical Microbiology and Infection, February 2009, Elsevier

    Dr Jacques F Meis

  289. Changing epidemiology of an emerging infection: zygomycosis

    Article • Clinical Microbiology and Infection, January 2009, Elsevier

    Dr Jacques F Meis

  290. Dose-response relationships of three amphotericin B formulations in a non-neutropenic murine model of invasive aspergillosis

    Article • Medical Mycology, January 2009, Oxford University Press (OUP)

    Dr Jacques F Meis

  291. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species

    Article • Medical Mycology, January 2009, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Hamid Badali

  292. Molecular typing of Aspergillus species

    Article • Mycoses, November 2008, Wiley

    Dr Jacques F Meis

  293. In Vitro Activities at pH 5.0 and pH 7.0 and In Vivo Efficacy of Flucytosine against Aspergillus fumigatus

    Article • Antimicrobial Agents and Chemotherapy, September 2008, ASM Journals

    Dr Jacques F Meis

  294. Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice 1

    Article • Medical Mycology, July 2008, Wiley

    Dr Jacques F Meis

  295. Utility of a microsatellite assay for identifying clonally related outbreak isolates of Aspergillus fumigatus

    Article • Journal of Microbiological Methods, June 2008, Elsevier

    Dr Jacques F Meis

  296. RespiFinder: a New Multiparameter Test To Differentially Identify Fifteen Respiratory Viruses

    Article • Journal of Clinical Microbiology, February 2008, ASM Journals

    Dr Jacques F Meis

  297. In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba

    Article • Antimicrobial Agents and Chemotherapy, January 2008, ASM Journals

    Dr Jacques F Meis

  298. Geographic and Temporal Trends in Isolation and Antifungal Susceptibility of Candida parapsilosis: a Global Assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

    Article • Journal of Clinical Microbiology, January 2008, ASM Journals

    Dr Jacques F Meis

  299. Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

    Article • Journal of Clinical Microbiology, December 2007, ASM Journals

    Dr Jacques F Meis

  300. Candida nivariensis Isolated from an Indonesian Human Immunodeficiency Virus-Infected Patient Suffering from Oropharyngeal Candidiasis

    Article • Journal of Clinical Microbiology, November 2007, ASM Journals

    Dr Jacques F Meis

  301. Retrotransposon insertion-site context (RISC) typing: A novel typing method for Aspergillus fumigatus and a convenient PCR alternative to restriction fragment length polymorphism analysis

    Article • Journal of Microbiological Methods, September 2007, Elsevier

    Dr Jacques F Meis

  302. Activity and post antifungal effect of chlorpromazine and trifluopherazine against Aspergillus, Scedosporium and zygomycetes

    Article • Mycoses, May 2007, Wiley

    Dr Jacques F Meis

  303. Hand hygiene and health-care-associated infections

    Article • The Lancet Infectious Diseases, May 2007, Elsevier

    Dr Jacques F Meis

  304. Microsatellite based typing of Aspergillus fumigatus: Strengths, pitfalls and solutions

    Article • Journal of Microbiological Methods, May 2007, Elsevier

    Dr Jacques F Meis

  305. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

    Article • Journal of Clinical Microbiology, April 2007, ASM Journals

    Dr Jacques F Meis

  306. Comparison of Two Highly Discriminatory Molecular Fingerprinting Assays for Analysis of Multiple Aspergillus fumigatus Isolates from Patients with Invasive Aspergillosis

    Article • Journal of Clinical Microbiology, March 2007, ASM Journals

    Dr Jacques F Meis

  307. P1978 In vitro activity of isavuconazole (BAL4815) compared with seven other antifungal agents against 309 prospectively collected clinical Candida isolates from the Netherlands

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Dr Jacques F Meis

  308. P1977 In vitro activity of isavuconazole (BAL4815/8557) compared with six other antifungal agents against 180 Cryptococcus neoformans meningitis isolates from the Netherlands

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Dr Jacques F Meis

  309. Candida rugosa, an Emerging Fungal Pathogen with Resistance to Azoles: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program

    Article • Journal of Clinical Microbiology, October 2006, ASM Journals

    Dr Jacques F Meis

  310. Candida guilliermondii, an Opportunistic Fungal Pathogen with Decreased Susceptibility to Fluconazole: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program

    Article • Journal of Clinical Microbiology, October 2006, ASM Journals

    Dr Jacques F Meis

  311. Clostridium cadaveris bacteraemia: Two cases and review

    Article • Scandinavian Journal of Infectious Diseases, January 2006, Taylor & Francis

    Dr Jacques F Meis

  312. Kunnen orale antimycotica de flora van het maag-darmkanaal beïnvloeden/verstoren?

    Article • January 2006, Springer Science + Business Media

    Dr Jacques F Meis

  313. Wat zijn de verschijnselen en wat is de behandeling van de huidaandoening schapenpokken of bekkieschurft?

    Article • January 2006, Springer Science + Business Media

    Dr Jacques F Meis

  314. 160 Colonization of Cystic Fibrosis patients with Aspergillus fumigatus is a recurrent phenomenon

    Article • Journal of Cystic Fibrosis, January 2006, Elsevier

    Dr Jacques F Meis

  315. A case of imported paracoccidioidomycosis: an awkward infection in the Netherlands

    Article • Medical Mycology, January 2006, Oxford University Press (OUP)

    Dr Jacques F Meis

  316. Efficacy and Pharmacodynamics of Flucytosine Monotherapy in a Nonneutropenic Murine Model of Invasive Aspergillosis

    Article • Antimicrobial Agents and Chemotherapy, October 2005, ASM Journals

    Dr Jacques F Meis

  317. Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands

    Article • Current Medical Research and Opinion, September 2005, Informa Healthcare

    Dr Jacques F Meis

  318. Relationship between In Vitro Activities of Amphotericin B and Flucytosine and pH for Clinical Yeast and Mold Isolates

    Article • Antimicrobial Agents and Chemotherapy, August 2005, ASM Journals

    Dr Jacques F Meis

  319. Use of a Novel Panel of Nine Short Tandem Repeats for Exact and High-Resolution Fingerprinting of Aspergillus fumigatus Isolates

    Article • Journal of Clinical Microbiology, August 2005, ASM Journals

    Dr Jacques F Meis

  320. Genetic Relatedness between Pneumococcal Populations Originating from the Nasopharynx, Adenoid, and Tympanic Cavity of Children with Otitis Media

    Article • Journal of Clinical Microbiology, July 2005, ASM Journals

    Dr Jacques F Meis

  321. Burkholderia fungorumSepticemia

    Article • Emerging Infectious Diseases, July 2005, Centers for Disease Control and Prevention (CDC)

    Dr Jacques F Meis, Professor Peter A Vandamme

  322. Assessingin vitrocombinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models

    Article • Medical Mycology, January 2005, Oxford University Press (OUP)

    Dr Jacques F Meis

  323. Pericarditis as complication of appendicitis

    Article • The Annals of Thoracic Surgery, September 2004, Elsevier

    Dr Jacques F Meis, Dr Edward Tan

  324. Effect of pH on the In Vitro Activities of Amphotericin B, Itraconazole, and Flucytosine against Aspergillus Isolates

    Article • Antimicrobial Agents and Chemotherapy, August 2004, ASM Journals

    Dr Jacques F Meis

  325. In Vitro Interactions between Amphotericin B, Itraconazole, and Flucytosine against 21 Clinical Aspergillus Isolates Determined by Two Drug Interaction Models

    Article • Antimicrobial Agents and Chemotherapy, June 2004, ASM Journals

    Dr Jacques F Meis

  326. Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue

    Article • Journal of Clinical Microbiology, April 2004, ASM Journals

    Dr Jacques F Meis, Maria M Traczewski

  327. An adult case of oral infection with Kingella kingae

    Article • International Journal of Oral and Maxillofacial Surgery, February 2004, Elsevier

    Dr Jacques F Meis

  328. Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis

    Article • Antimicrobial Agents and Chemotherapy, November 2003, ASM Journals

    Dr Jacques F Meis, Dr Eric Dannaoui

  329. Molecular Epidemiology of Aspergillus fumigatus Isolates Recovered from Water, Air, and Patients Shows Two Clusters of Genetically Distinct Strains

    Article • Journal of Clinical Microbiology, September 2003, ASM Journals

    Dr Jacques F Meis

  330. Quality Control Limits for Fluconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue

    Article • Journal of Clinical Microbiology, July 2003, ASM Journals

    Dr Jacques F Meis, Maria M Traczewski

  331. Antifungal activity of human polymorphonuclear and mononuclear phagocytes against non-fumigatus Aspergillus species. Phagozytose-Aktivitat humaner polymorphonuklearer und monouklearer Phagozyten gegen Nicht-fumigatus-Aspergillus-Arten

    Article • Mycoses, March 2003, Wiley

    Dr Jacques F Meis

  332. In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates

    Article • Antimicrobial Agents and Chemotherapy, January 2003, ASM Journals

    Dr Jacques F Meis

  333. Evaluation of a polymerase chain reaction reverse hybridization line probe assay for the detection and identification of medically important fungi in bronchoalveolar lavage fluids

    Article • Medical Mycology, January 2003, Oxford University Press (OUP)

    Dr Jacques F Meis

  334. Interactions of human phagocytes with mouldsFusariumspp. andVerticilliumnigrescenspossessing different pathogenicity1

    Article • Medical Mycology, January 2003, Oxford University Press (OUP)

    Dr Jacques F Meis

  335. In vitro susceptibilities of zygomycetes to conventional and new antifungals

    Article • Journal of Antimicrobial Chemotherapy, November 2002, Oxford University Press (OUP)

    Dr Jacques F Meis, Dr Eric Dannaoui

  336. In Vitro Synergistic Interaction between Amphotericin B and Pentamidine against Scedosporium prolificans

    Article • Antimicrobial Agents and Chemotherapy, October 2002, ASM Journals

    Dr Jacques F Meis, Dr Eric Dannaoui

  337. In Vitro Interaction of Flucytosine Combined with Amphotericin B or Fluconazole against Thirty-Five Yeast Isolates Determined by both the Fractional Inhibitory Concentration Index and the Response Surface Approach

    Article • Antimicrobial Agents and Chemotherapy, September 2002, ASM Journals

    Dr Jacques F Meis

  338. In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial Agents

    Article • Antimicrobial Agents and Chemotherapy, August 2002, ASM Journals

    Dr Jacques F Meis, Dr Eric Dannaoui

  339. Comparison of the Etest and the Sensititre Colorimetric Methods with the NCCLS Proposed Standard for Antifungal Susceptibility Testing of Aspergillus Species

    Article • Journal of Clinical Microbiology, August 2002, ASM Journals

    Dr Jacques F Meis

  340. POST ANTIFUNGAL EFFECT OF EXOPHIALA SPINIFERA STRAINS AGAINST AMPHOTERICIN B, ITRACONAZOLE, TERBINAFINE AND 5‐FLUOROCYTOSINE

    Article • Mycoses, August 2002, Wiley

    Dr Jacques F Meis

  341. IN VITRO ACTIVITY OF AMPHOTERICIN B AND ITRACONAZOLE IN COMBINATION WITH 5-FLUOROCYTOSINE, SULFADIAZINE AND QUINOLONES AGAINST EXOPHIALA SPINIFERA STRAINS

    Article • Mycoses, August 2002, Wiley

    Dr Jacques F Meis

  342. Methodological issues related to antifungal drug interaction modelling for filamentous fungi

    Article • Reviews in Medical Microbiology, July 2002, Wolters Kluwer Health

    Dr Jacques F Meis

  343. Nationwide Survey of In Vitro Activities of Itraconazole and Voriconazole against Clinical Aspergillus fumigatus Isolates Cultured between 1945 and 1998

    Article • Journal of Clinical Microbiology, July 2002, ASM Journals

    Dr Jacques F Meis

  344. Efficacy of Antifungal Therapy in a Nonneutropenic Murine Model of Zygomycosis

    Article • Antimicrobial Agents and Chemotherapy, June 2002, ASM Journals

    Dr Jacques F Meis, Dr Eric Dannaoui

  345. Method for Measuring Postantifungal Effect in Aspergillus Species

    Article • Antimicrobial Agents and Chemotherapy, June 2002, ASM Journals

    Dr Jacques F Meis

  346. In Vitro Activities of Pentamidine, Pyrimethamine, Trimethoprim, and Sulfonamides against Aspergillus Species

    Article • Antimicrobial Agents and Chemotherapy, June 2002, ASM Journals

    Dr Jacques F Meis

  347. Aspergillus galactomannan antigen levels in allogeneic haematopoietic stem cell transplant recipients given total parenteral nutrition

    Article • Transplant Infectious Disease, June 2002, Wiley

    Dr Jacques F Meis

  348. Pharmacological agents in development for invasive aspergillosis

    Article • Expert Opinion on Emerging Drugs, May 2002, Informa Healthcare

    Dr Jacques F Meis

  349. Comparison of Fractional Inhibitory Concentration Index with Response Surface Modeling for Characterization of In Vitro Interaction of Antifungals against Itraconazole-Susceptible and -Resistant Aspergillus fumigatus Isolates

    Article • Antimicrobial Agents and Chemotherapy, March 2002, ASM Journals

    Dr Jacques F Meis

  350. Identification of Four Distinct Genotypes of Candida dubliniensis and Detection of Microevolution In Vitro and In Vivo

    Article • Journal of Clinical Microbiology, February 2002, ASM Journals

    Dr Jacques F Meis, David C Coleman

  351. In Vitro Activities of New and Conventional Antifungal Agents against Clinical Scedosporium Isolates

    Article • Antimicrobial Agents and Chemotherapy, January 2002, ASM Journals

    Dr Jacques F Meis

  352. Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

    Article • Clinical Infectious Diseases, January 2002, Oxford University Press (OUP)

    Dr Jacques F Meis

  353. Comparison of Spectrophotometric and Visual Readings of NCCLS Method and Evaluation of a Colorimetric Method Based on Reduction of a Soluble Tetrazolium Salt, 2,3-Bis {2-Methoxy-4-Nitro-5-[(Sulfenylamino) Carbonyl]-2H- Tetrazolium-Hydroxide}, for Antif...

    Article • Journal of Clinical Microbiology, December 2001, ASM Journals

    Dr Jacques F Meis

  354. Colorimetric Assay for Antifungal Susceptibility Testing of Aspergillus Species

    Article • Journal of Clinical Microbiology, September 2001, ASM Journals

    Dr Jacques F Meis

  355. Meningococcal Disease

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2001, New England Journal of Medicine (NEJM/MMS)

    Dr Jacques F Meis

  356. Prevention of invasive aspergillosis in AIDS by sulfamethoxazole

    Article • AIDS, May 2001, Wolters Kluwer Health

    Dr Jacques F Meis

  357. Cystatin M/E Expression is Restricted to Differentiated Epidermal Keratinocytes and Sweat Glands: a New Skin-Specific Proteinase Inhibitor that is a Target for Cross-Linking by Transglutaminase

    Article • Journal of Investigative Dermatology, May 2001, Elsevier

    Dr Jacques F Meis

  358. A two year global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion

    Article • Diagnostic Microbiology and Infectious Disease, April 2001, Elsevier

    Dr Jacques F Meis

  359. Analysis of Growth Characteristics of Filamentous Fungi in Different Nutrient Media

    Article • Journal of Clinical Microbiology, February 2001, ASM Journals

    Dr Jacques F Meis

  360. The Plasmodium falciparum knob-associated PfEMP3 antigen is also expressed at pre-erythrocytic stages and induces antibodies which inhibit sporozoite invasion

    Article • Molecular and Biochemical Parasitology, February 2001, Elsevier

    Dr Jacques F Meis

  361. Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit

    Article • Journal of Hospital Infection, February 2001, Elsevier

    Dr Jacques F Meis

  362. Current Management of Fungal Infections

    Article • Drugs, January 2001, Springer Science + Business Media

    Dr Jacques F Meis

  363. Fungal Infections: The Role of Prophylaxis and Empiric Therapy in ICU Patients

    Article • January 2001, Springer Science + Business Media

    Dr Jacques F Meis

  364. Critical assessment of issues in the diagnosis of invasive aspergillosis

    Article • Clinical Microbiology and Infection, January 2001, Elsevier

    Dr Jacques F Meis

  365. Phagocytosis and Killing of Candida albicans by Human Neutrophils After Exposure to Structurally Different Lipid Emulsions

    Article • Journal of Parenteral and Enteral Nutrition, January 2001, Wiley

    Dr Jacques F Meis

  366. The VISA/GISA problem: therapeutic implications

    Article • Clinical Microbiology and Infection, January 2001, Elsevier

    Dr Jacques F Meis

  367. Invasive aspergillosis

    Article • Medical Mycology, December 2000, Oxford University Press (OUP)

    Dr Jacques F Meis

  368. Invasive aspergillosis

    Article • Medical Mycology, December 2000, Oxford University Press (OUP)

    Dr Jacques F Meis

  369. Declining number of patients with cryptococcosis in the Netherlands in the era of highly active antiretroviral therapy

    Article • AIDS, December 2000, Wolters Kluwer Health

    Dr Jacques F Meis

  370. Prevalence of Vancomycin-Resistant Enterococci in Europe

    Article • European Journal of Clinical Microbiology & Infectious Diseases, December 2000, Springer Science + Business Media

    Dr Jacques F Meis

  371. Article • Nature Reports Stem Cells, December 2000, Springer Science + Business Media

    Dr Jacques F Meis

  372. Procalcitonin Does Not Discriminate Infection from Inflammation after Allogeneic Bone Marrow Transplantation

    Article • Clinical and Diagnostic Laboratory Immunology, November 2000, ASM Journals

    Dr Jacques F Meis

  373. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3

    Article • Nature Reports Stem Cells, November 2000, Springer Science + Business Media

    Dr Jacques F Meis

  374. In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs

    Article • Mycoses, September 2000, Wiley

    Dr Jacques F Meis

  375. Hyaluronic acid-based agents do not affect anastomotic strength in the rat colon, in either the presence or absence of bacterial peritonitis

    Article • BJS, September 2000, Oxford University Press (OUP)

    Dr Jacques F Meis

  376. pH-dependent activity of amphotericin B

    Article • BJS, July 2000, Wiley

    Dr Jacques F Meis

  377. Role of cytokines of the tumour necrosis factor family in the immune response to disseminated Candida albicans infection

    Article • BJS, July 2000, Oxford University Press (OUP)

    Dr Jacques F Meis

  378. Risk factors in surgical patients with intra-abdominal Candida infection in intensive care

    Article • BJS, July 2000, Oxford University Press (OUP)

    Dr Jacques F Meis

  379. Prophylaxis and treatment of fungal infections associated with haematological malignancies

    Article • International Journal of Antimicrobial Agents, July 2000, Elsevier

    Dr Jacques F Meis

  380. Reply

    Article • The Journal of Infectious Diseases, June 2000, Oxford University Press (OUP)

    Dr Jacques F Meis

  381. Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans

    Article • Clinical Microbiology and Infection, June 2000, Elsevier

    Dr Jacques F Meis

  382. Atypical presentation of Madurella mycetomatis mycetoma in a renal transplant patient

    Article • Transplant Infectious Disease, June 2000, Wiley

    Dr Jacques F Meis

  383. Microbiological diagnosis of invasive fungal infections in transplant recipients

    Article • Transplant Infectious Disease, June 2000, Wiley

    Dr Jacques F Meis

  384. Earlier Initiation of Antibiotic Treatment for Severe Infections After Interventions to Improve the Organization and Specific Guidelines in the Emergency Department

    Article • Archives of Internal Medicine, May 2000, American Medical Association (AMA)

    Dr Jacques F Meis

  385. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion

    Article • Diagnostic Microbiology and Infectious Disease, April 2000, Elsevier

    Dr Jacques F Meis

  386. In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificans

    Article • Antimicrobial Agents and Chemotherapy, February 2000, ASM Journals

    Dr Jacques F Meis

  387. Cervical Spinal Epidural Abscess Due to Group B Streptococcus in a Previously Healthy Elderly Male

    Article • Scandinavian Journal of Infectious Diseases, January 2000, Taylor & Francis

    Dr Jacques F Meis

  388. Invasive aspergillosis

    Article • Medical Mycology, January 2000, Oxford University Press (OUP)

    Dr Jacques F Meis

  389. Invasive aspergillosis

    Article • Medical Mycology, January 2000, Oxford University Press (OUP)

    Dr Jacques F Meis

  390. Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice 1

    Article • Medical Mycology, December 1999, Wiley

    Dr Jacques F Meis

  391. Fas‐FasL Interactions Modulate Host Defense against SystemicCandida albicansInfection

    Article • The Journal of Infectious Diseases, November 1999, Oxford University Press (OUP)

    Dr Jacques F Meis

  392. Reply to Letter to the Editor of J.H. van Loenhout-Rooyackers [published in the September issue of The Netherlands Journal of Medicine (1999;55:163)]

    Article • The Netherlands Journal of Medicine, November 1999, Elsevier

    Dr Jacques F Meis

  393. Prevention of Intra-abdominal Abscesses and Adhesions Using a Hyaluronic Acid Solution in a Rat Peritonitis Model

    Article • Archives of Surgery, September 1999, American Medical Association (AMA)

    Dr Jacques F Meis

  394. INVASIVE ASPERGILLOSIS IN TWO PATIENTS WITH PEARSON SYNDROME

    Article • The Pediatric Infectious Disease Journal, August 1999, Wolters Kluwer Health

    Dr Jacques F Meis

  395. Nosocomial fungal infections: candidemia

    Article • Diagnostic Microbiology and Infectious Disease, July 1999, Elsevier

    Dr Jacques F Meis

  396. Infusion of Lipoproteins into Volunteers Enhances the Growth of Candida albicans

    Article • Clinical Infectious Diseases, May 1999, Oxford University Press (OUP)

    Dr Jacques F Meis

  397. Perianal ulcer

    Article • The Lancet, May 1999, Elsevier

    Dr Jacques F Meis

  398. Comparative study of seven commercial yeast identification systems.

    Article • Journal of Clinical Pathology, April 1999, BMJ

    Dr Jacques F Meis

  399. Candida dubliniensis Candidemia in Patients with Chemotherapy-Induced Neutropenia and Bone Marrow Transplantation

    Article • Emerging Infectious Diseases, February 1999, Centers for Disease Control and Prevention (CDC)

    Dr Jacques F Meis

  400. Swelling of hand and forearm caused by Mycobacterium bovis

    Article • The Netherlands Journal of Medicine, February 1999, Elsevier

    Dr Jacques F Meis

  401. Induction of SLPI (ALP/HUSI-I) in Epidermal Keratinocytes

    Article • Journal of Investigative Dermatology, December 1998, Elsevier

    Dr Jacques F Meis

  402. Delay in Administering the First Dose of Antibiotics in Patients Admitted to Hospital with Serious Infections

    Article • European Journal of Clinical Microbiology & Infectious Diseases, November 1998, Springer Science + Business Media

    Dr Jacques F Meis

  403. Prevalence of antibodies to Histoplasma capsulatum among dutch speleologists

    Article • Journal of Infection, September 1998, Elsevier

    Dr Jacques F Meis

  404. In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

    Article • Journal of Antimicrobial Chemotherapy, September 1998, Oxford University Press (OUP)

    Dr Jacques F Meis

  405. Functional and morphological monocyte abnormalities in a patient with malakoplakia

    Article • The American Journal of Medicine, July 1998, Elsevier

    Dr Jacques F Meis

  406. Cefpirome: Epidemiological Survey in Intensive Care Units and Hematological Units in the Netherlands

    Article • Diagnostic Microbiology and Infectious Disease, July 1998, Elsevier

    Dr Jacques F Meis

  407. In situ localisation of Yersinia enterocolitica by catalysed reported deposition signal amplification.

    Article • Journal of Clinical Pathology, June 1998, BMJ

    Dr Jacques F Meis

  408. Nosocomial outbreak of colonization and infection with Stenotrophomonas maltophilia in preterm infants associated with contaminated tap water

    Article • Epidemiology and Infection, June 1998, Cambridge University Press

    Dr Jacques F Meis

  409. Characterization of Pathogenetic Determinants of Candida albicans Strains

    Article • Zentralblatt für Bakteriologie, May 1998, Elsevier

    Dr Jacques F Meis

  410. Successful Treatment with Voriconazole of Invasive Aspergillosis in Chronic Granulomatous Disease

    Article • American Review of Respiratory Disease, May 1998, American Thoracic Society

    Dr Jacques F Meis

  411. Microgranulomatous Aspergillosis in a Patient with Chronic Granulomatous Disease: Cure with Voriconazole

    Article • Clinical Infectious Diseases, April 1998, Oxford University Press (OUP)

    Dr Jacques F Meis

  412. LOCAL EXPRESSION OF CYTOKINE mRNA IN SPLEEN AND PEYER'S PATCHES OF RATS IS INVOLVED IN RESISTANCE AGAINST INFECTION WITHYERSINIA ENTEROCOLITICA

    Article • Cytokine, March 1998, Elsevier

    Dr Jacques F Meis

  413. Evaluation of the discriminatory power of pulsed-field gel electrophoresis and PCR fingerprinting for epidemiologic typing of Candida species

    Article • Clinical Microbiology and Infection, February 1998, Elsevier

    Dr Jacques F Meis

  414. Recombinant Murine Granulocyte Colony‐Stimulating Factor Protects against Acute DisseminatedCandida albicansInfection in Nonneutropenic Mice

    Article • The Journal of Infectious Diseases, January 1998, Oxford University Press (OUP)

    Dr Jacques F Meis

  415. Resistance of Aspergillus fumigatus to Itraconazole

    Article • Scandinavian Journal of Infectious Diseases, January 1998, Taylor & Francis

    Dr Jacques F Meis

  416. Sepsis puerperalis caused by a genotypically proven cat-derived Pasteurella multocida strain

    Article • European Journal of Obstetrics & Gynecology and Reproductive Biology, January 1998, Elsevier

    Dr Jacques F Meis

  417. Progress in fighting systemic fungal infections in haematological neoplasia

    Article • Supportive Care in Cancer, December 1997, Springer Science + Business Media

    Dr Jacques F Meis

  418. Two Strategies for Managing Invasive Aspergillosis: A Decision Analysis

    Article • Clinical Infectious Diseases, November 1997, Oxford University Press (OUP)

    Dr Jacques F Meis

  419. The detection of Aspergillus fumigatus DNA by PCR-ELISA

    Article • Journal of Microbiological Methods, September 1997, Elsevier

    Dr Jacques F Meis

  420. Arthritis and spondylodiscitis caused by Mycobacterium xenopi in a patient with systemic lupus erythematosus

    Article • Rheumatology, September 1997, Oxford University Press (OUP)

    Dr Jacques F Meis

  421. Two-step polymerase chain reaction assay for detection of Yersinia species in general and of pathogenic Yersinia enterocolitica strains specifically

    Article • International Journal of Infectious Diseases, April 1997, Elsevier

    Dr Jacques F Meis

  422. POLYENE THERAPY FOR CANDIDA INFECTION

    Article • Shock, March 1997, Wolters Kluwer Health

    Dr Jacques F Meis

  423. Serial monitoring ofAspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples

    Article • Infection, March 1997, Springer Science + Business Media

    Dr Jacques F Meis

  424. Candida tropicalis arthritis in a patient with acute myeloid leukemia successfully treated with fluconazole: Case report and review of the literature

    Article • Infection, March 1997, Springer Science + Business Media

    Dr Jacques F Meis

  425. Pseudo-Outbreak of Multiresistant Pseudomonas aeruginosa in a Hematology Unit

    Article • Infection Control, February 1997, JSTOR

    Dr Jacques F Meis

  426. Pseudo-Outbreak of Multiresistant Pseudomonas aeruginosa in a Hematology Unit

    Article • Infection Control, February 1997, Cambridge University Press

    Dr Jacques F Meis

  427. Analysis of an outbreak of puerperal fever due to group A streptococci by random amplified polymorphic DNA fingerprinting

    Article • Infectious Diseases in Obstetrics and Gynecology, January 1997, Wiley

    Dr Jacques F Meis

  428. Analysis of an outbreak of puerperal fever due to group A streptococci by random amplified polymorphic DNA fingerprinting

    Article • Infectious Diseases in Obstetrics and Gynecology, January 1997, Wiley

    Dr Jacques F Meis

  429. Analysis of an Outbreak of Puerperal Fever Due to Group A Streptococci by Random Amplified Polymorphic DNA Fingerprinting

    Article • Infectious Diseases in Obstetrics and Gynecology, January 1997, Hindawi Publishing Corporation

    Dr Jacques F Meis

  430. Candidemia in intensive care unit patients: Risk factors for mortality

    Article • Infection, January 1997, Springer Science + Business Media

    Dr Jacques F Meis

  431. Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy

    Article • European Journal of Clinical Microbiology & Infectious Diseases, January 1997, Springer Science + Business Media

    Dr Jacques F Meis

  432. Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals

    Article • European Journal of Clinical Microbiology & Infectious Diseases, December 1996, Springer Science + Business Media

    Dr Jacques F Meis

  433. High-Dose Itraconazole for the Treatment of Cerebral Aspergillosis

    Article • Clinical Infectious Diseases, November 1996, Oxford University Press (OUP)

    Dr Jacques F Meis

  434. Staphylococcus epidermidis Catheter-Related Infections in a Short-Bowel Patient. Persistence of a Single Strain over a Two-Year Period

    Article • Infection Control, October 1996, JSTOR

    Dr Jacques F Meis

  435. Staphylococcus epidermidis Catheter-Related Infections in a Short-Bowel Patient. Persistence of a Single Strain Over a Two-Year Period

    Article • Infection Control, October 1996, Cambridge University Press

    Dr Jacques F Meis

  436. Immunoperoxidase staining for identification of Aspergillus species in routinely processed tissue sections.

    Article • Journal of Clinical Pathology, October 1996, BMJ

    Dr Jacques F Meis

  437. Staphylococcus epidermidis Catheter-Related Infections in a Short-Bowel Patient. Persistence of a Single Strain Over a Two-Year Period

    Article • Infection Control, October 1996, Cambridge University Press

    Dr Jacques F Meis

  438. Prospects for the early diagnosis of invasive aspergillosis in the immunocompromised patient

    Article • Reviews in Medical Microbiology, April 1996, Wolters Kluwer Health

    Dr Jacques F Meis

  439. Helicobacter cinaedi Bacteremia Associated with Localized Pain but Not with Cellulitis

    Article • Clinical Infectious Diseases, April 1996, Oxford University Press (OUP)

    Dr Jacques F Meis

  440. Use of Interrepeat PCR Fingerprinting to Investigate an Acinetobacter baumannii Outbreak in an Intensive Care Unit

    Article • Scandinavian Journal of Infectious Diseases, January 1996, Taylor & Francis

    Dr Jacques F Meis

  441. Interactions of Yersinia enterocolitica with polarized human intestinal Caco-2 cells

    Article • Medical Microbiology and Immunology, October 1995, Springer Science + Business Media

    Dr Jacques F Meis

  442. PCR-based characterization ofYersinia enterocolitica: comparison with biotyping and serotyping

    Article • Epidemiology and Infection, October 1995, Cambridge University Press

    Dr Jacques F Meis

  443. Epidemiological survey of an outbreak of multiresistantSerratia marcescens by PCR-fingerprinting

    Article • Infection, September 1995, Springer Science + Business Media

    Dr Jacques F Meis

  444. Characterization of verocytotoxin-producingEscherichia coliO157 isolates from patients with haemolytic uraemic syndrome in Western Europe

    Article • Epidemiology and Infection, August 1995, Cambridge University Press

    Dr Jacques F Meis

  445. Persistent Yersinia enterocolitica infection in three rat strains

    Article • Microbial Pathogenesis, July 1995, Elsevier

    Dr Jacques F Meis

  446. A Brain Abscess Due to Multiply-Resistant Enterobacter cloacae Successfully Treated with Meropenem

    Article • Clinical Infectious Diseases, June 1995, Oxford University Press (OUP)

    Dr Jacques F Meis

  447. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis.

    Article • Journal of Clinical Pathology, May 1995, BMJ

    Dr Jacques F Meis

  448. Septic shock caused by group G β-haemolytic streptococci as presenting symptom of acute myeloid leukaemia

    Article • The Netherlands Journal of Medicine, March 1995, Elsevier

    Dr Jacques F Meis

  449. Severe Human Psittacosis Requiring Artificial Ventilation: Case Report and Review

    Article • Clinical Infectious Diseases, February 1995, Oxford University Press (OUP)

    Dr Jacques F Meis

  450. Disseminated Abscesses Caused by Rhodococcus equi in a Patient with Chronic Lymphocytic Leukemia

    Article • Clinical Infectious Diseases, February 1995, Oxford University Press (OUP)

    Dr Jacques F Meis

  451. An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy

    Article • Annals of Hematology, February 1995, Springer Science + Business Media

    Dr Jacques F Meis

  452. Bacteremia Due to Oral Viridans Streptococci in Neutropenic Patients with Cancer: Cytostatics Are a More Important Risk Factor than Antibacterial Prophylaxis

    Article • Clinical Infectious Diseases, February 1995, Oxford University Press (OUP)

    Dr Jacques F Meis

  453. Interrepeat Fingerprinting of Third-Generation Cephalosporin-Resistant Enterobacter cloacae Isolated during an Outbreak in a Neonatal Intensive Care Unit

    Article • Infection Control, January 1995, JSTOR

    Dr Jacques F Meis

  454. In-vitro antimicrobial susceptibility of Yersinia enterocolitica isolates from stools of patients in The Netherlands from 1982–1991

    Article • Journal of Antimicrobial Chemotherapy, January 1995, Oxford University Press (OUP)

    Dr Jacques F Meis

  455. Interrepeat Fingerprinting of Third- Generation Cephalosporin-Resistant Enterobacter cloacae Isolated During an Outbreak in a Neonatal Intensive Care Unit

    Article • Infection Control, January 1995, Cambridge University Press

    Dr Jacques F Meis

  456. Phylogenetic relationships of five species of Aspergillus and related taxa as deduced by comparison of sequences of small subunit ribosomal RNA

    Article • Medical Mycology, January 1995, Oxford University Press (OUP)

    Dr Jacques F Meis

  457. Polymerase chain reaction as a diagnostic tool for invasive aspergillosis: evaluation in bronchoalveolar lavage fluid from low risk patients

    Article • Serodiagnosis and Immunotherapy in Infectious Disease, December 1994, Elsevier

    Dr Jacques F Meis

  458. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants

    Article • The Journal of Immunology, December 1994, The American Association of Immunologists

    Dr Jacques F Meis

  459. COLONIZATION OF THE FEMALE GENITAL TRACT WITH HAEMOPHILUS INFLUENZAE

    Article • The Pediatric Infectious Disease Journal, August 1994, Wolters Kluwer Health

    Dr Jacques F Meis

  460. Fluconazole in the management of fungal urinary tract infections

    Article • Infection, July 1994, Springer Science + Business Media

    Dr Jacques F Meis

  461. Polymerase Chain Reaction--Mediated Genotyping in Microbial Epidemiology

    Article • Clinical Infectious Diseases, June 1994, Oxford University Press (OUP)

    Dr Jacques F Meis

  462. Genotypic Characterization of Sequential Candida albicans Isolates from Fluconazole-Treated Neutropenic Patients

    Article • The Journal of Infectious Diseases, May 1994, Oxford University Press (OUP)

    Dr Jacques F Meis

  463. Reply

    Article • Clinical Infectious Diseases, March 1994, Oxford University Press (OUP)

    Dr Jacques F Meis

  464. Pneumopericardium complicating invasive pulmonary aspergillosis: Case report and review

    Article • Infection, March 1994, Springer Science + Business Media

    Dr Jacques F Meis

  465. Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

    Article • Infection, March 1994, Springer Science + Business Media

    Dr Jacques F Meis

  466. Cellulitis as First Clinical Presentation of Disseminated Cryptococcosis in Renal Transplant Recipients

    Article • Scandinavian Journal of Infectious Diseases, January 1994, Taylor & Francis

    Dr Jacques F Meis

  467. Endophthalmitis as presenting symptom of group G streptococcal endocarditis

    Article • Infection, January 1994, Springer Science + Business Media

    Dr Jacques F Meis

  468. CROSS-INFECTION WITH PSEUDOMONAS AERUGINOSA IN A NEONATAL INTENSIVE CARE UNIT CHARACTERIZED BY POLYMERASE CHAIN REACTION FINGERPRINTING

    Article • The Pediatric Infectious Disease Journal, December 1993, Wolters Kluwer Health

    Dr Jacques F Meis

  469. FatalClostridium perfringens meningitis associated with insertion of a ventriculo-peritoneal shunt

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 1993, Springer Science + Business Media

    Dr Jacques F Meis

  470. Infections caused by Gemella morbillorum

    Article • The Lancet, August 1993, Elsevier

    Dr Jacques F Meis

  471. Diagnosing meningococcal infection: Don't delay giving antibiotics: Authors' reply

    Article • BMJ, July 1993, BMJ

    Dr Jacques F Meis

  472. PYOSALPINX CAUSED BY STREPTOCOCCUS PNEVMONIAE IN A YOUNG GIRL

    Article • The Pediatric Infectious Disease Journal, June 1993, Wolters Kluwer Health

    Dr Jacques F Meis

  473. Rapid diagnosis of acute meningococcal infections by needle aspiration or biopsy of skin lesions.

    Article • BMJ, May 1993, BMJ

    Dr Jacques F Meis

  474. Multiple brain abscesses and bacteremia in a child due toFusobacterium necrophorum

    Article • Infection, May 1993, Springer Science + Business Media

    Dr Jacques F Meis

  475. Aspergillus fumigatus Pneumonia in Neutropenic Patients During Therapy with Fluconazole for Infection Due to Candida Species

    Article • Clinical Infectious Diseases, May 1993, Oxford University Press (OUP)

    Dr Jacques F Meis

  476. No Evidence for a Relation Between Borrelia burgdorferi Infection and Old Lesions of Localized Scleroderma (Morphea)

    Article • Archives of Dermatology, March 1993, American Medical Association (AMA)

    Dr Jacques F Meis

  477. No evidence for a relation between Borrelia burgdorferi infection and old lesions of localized scleroderma (morphea)

    Article • Archives of Dermatology, March 1993, American Medical Association (AMA)

    Dr Jacques F Meis

  478. CHRONIC POLYARTHRLTIS DUE TO PSEUDOMONAS AERUGINOSA

    Article • Rheumatology, January 1993, Oxford University Press (OUP)

    Dr Jacques F Meis

  479. Fatal Intrauterine Infection Associated with Mycoplasma hominis

    Article • Clinical Infectious Diseases, October 1992, Oxford University Press (OUP)

    Dr Jacques F Meis

  480. Kingella kingae Intervertebral Diskitis in an Adult

    Article • Clinical Infectious Diseases, September 1992, Oxford University Press (OUP)

    Dr Jacques F Meis

  481. Acute renal failure in a neonate due to pelviureteric candidal bezoars successfully treated with long‐term systemic fluconazole

    Article • Acta Paediatrica, September 1992, Wiley

    Dr Jacques F Meis

  482. Rapidly fatal Q-fever pneumonia in a patient with chronic granulomatous disease

    Article • Infection, September 1992, Springer Science + Business Media

    Dr Jacques F Meis

  483. Erysipelas-like skin lesions associated withCampylobacter jejuni septicemia in patients with hypogammaglobulinemia

    Article • European Journal of Clinical Microbiology & Infectious Diseases, September 1992, Springer Science + Business Media

    Dr Jacques F Meis

  484. Transmission blocking antibody of the Plasmodium falciparum zygote/ookinete surface protein Pfs25 also influences sporozoite development

    Article • Parasite Immunology, September 1992, Wiley

    Dr Jacques F Meis

  485. A scanning electron microscopic study of the sporogonic development of Plasmodium falciparum in Anopheles stephensi

    Article • Acta Tropica, February 1992, Elsevier

    Dr Jacques F Meis

  486. Localization of circumsporozoite protein in the sporogonic stages ofPlasmodium vivax

    Article • Zeitschrift für Parasitenkunde Parasitology Research, February 1992, Springer Science + Business Media

    Dr Jacques F Meis

  487. Primary structure and localization of a conserved immunogenicPlasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle

    Article • Molecular and Biochemical Parasitology, November 1991, Elsevier

    Dr Jacques F Meis

  488. A novel protein antigen of the malaria parasite Plasmodium falciparum, located on the surface of gametes and sporozoites

    Article • Molecular and Biochemical Parasitology, April 1991, Elsevier

    Dr Jacques F Meis

  489. Detection of different developmental stages of malaria parasites by non-radioactive DNAin situ hybridization

    Article • The Histochemical Journal, March 1991, Springer Science + Business Media

    Dr Jacques F Meis

  490. Fulminant Neonatal Sepsis due to Haemophilus influenzae

    Article • Scandinavian Journal of Infectious Diseases, January 1991, Taylor & Francis

    Dr Jacques F Meis

  491. Non-CS pre-erythrocytic protective antigens

    Article • Immunology Letters, August 1990, Elsevier

    Dr Jacques F Meis

  492. Bordetella bronchiseptica bronchitis in an immunosuppressed patient

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 1990, Springer Science + Business Media

    Dr Jacques F Meis

  493. Plasmodium falciparum: Studies on mature exoerythrocytic forms in the liver of the chimpanzee, Pan troglodytes

    Article • Experimental Parasitology, January 1990, Elsevier

    Dr Jacques F Meis

  494. Plasmodium falciparum ookinetes migrate intercellularly throughAnopheles stephensi midgut epithelium

    Article • Zeitschrift für Parasitenkunde Parasitology Research, January 1989, Springer Science + Business Media

    Dr Jacques F Meis

  495. Exoerythrocytic Development of Malarial Parasites

    Article • January 1988, Elsevier

    Dr Jacques F Meis

  496. Immunogold localization of circumsporozoite proteins of plasmodium falciparum in a mosquito vector (Anopheles stevensi)

    Article • Ultramicroscopy, January 1988, Elsevier

    Dr Jacques F Meis

  497. Interaction of malaria with mosquitoes

    Article • Parasitology Today, December 1987, Elsevier

    Dr Jacques F Meis

  498. Cellular Response against Exoerythrocytic forms of Plasmodium Berghei in Rats

    Article • American Journal of Tropical Medicine and Hygiene, November 1987, American Society of Tropical Medicine and Hygiene

    Dr Jacques F Meis

  499. Ultrastructural studies on the interaction of Plasmodium falciparum ookinetes with the midgut epithelium of Anopheles stephensi mosquitoes

    Article • January 1987, Springer Science + Business Media

    Dr Jacques F Meis

  500. Immuno-Electron Microscopic Observations on Plasmodium Falciparum Sporozoites Using Ultracryomicrotomy

    Article • January 1987, Springer Science + Business Media

    Dr Jacques F Meis

  501. Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system

    Article • Parasitology, October 1986, Cambridge University Press

    Dr Jacques F Meis

  502. Fine structure of the malaria parasite Plasmodium falciparum in human hepatocytes in vitro

    Article • Cell and Tissue Research, May 1986, Springer Science + Business Media

    Dr Jacques F Meis

  503. Fine Structure of Exoerythrocytic Merozoite Formation of Plasmodium berghei in Rat Liver1

    Article • The Journal of Protozoology, November 1985, Wiley

    Dr Jacques F Meis

  504. Infection of cryopreserved adult human hepatocytes with sporozoites

    Article • Cell Biology International Reports, November 1985, Wiley

    Dr Jacques F Meis

  505. Transformation of sporozoites of Plasmodium berghei into exoerythrocytic forms in the liver of its mammalian host

    Article • Cell and Tissue Research, August 1985, Springer Science + Business Media

    Dr Jacques F Meis

  506. Electron microscopic studies on the interaction of rat Kupffer cells andPlasmodium berghei sporozoites

    Article • January 1985, Springer Science + Business Media

    Dr Jacques F Meis

  507. Intranuclear localization of sporozoites

    Article • Cell Biology International Reports, December 1984, Wiley

    Dr Jacques F Meis

  508. The biology of tissue forms and other asexual stages in mammalian plasmodia

    Article • Cellular and Molecular Life Sciences, December 1984, Springer Science + Business Media

    Dr Jacques F Meis

  509. Fine structure of exoerythrocytic forms in cultured primary rat hepatocytes

    Article • Cell Biology International Reports, September 1984, Wiley

    Dr Jacques F Meis, Dr Hans M Princen

  510. IN-VITRO CULTURE OF EXOERYTHROCYTIC FORM OF PLASMODIUM FALCIPARUM IN ADULT HUMAN HEPATOCYTES

    Article • The Lancet, September 1984, Elsevier

    Dr Jacques F Meis

  511. Histochemical observations on the exoerythrocytic malaria parasite Plasmodium berghei in rat liver

    Article • Histochemistry and Cell Biology, January 1984, Springer Science + Business Media

    Dr Jacques F Meis

  512. Ultrastructural Observations on the Infection of Rat Liver by Plasmodium berghei Sporozoites In Vivo1

    Article • The Journal of Protozoology, May 1983, Wiley

    Dr Jacques F Meis

  513. An ultrastructural study on the role of Kupffer cells in the process of infection by Plasmodium berghei sporozoites in rats

    Article • Parasitology, April 1983, Cambridge University Press

    Dr Jacques F Meis

  514. Malaria parasites—discovery of the early liver form

    Article • Nature, March 1983, Springer Science + Business Media

    Dr Jacques F Meis

  515. Ultrastructural Studies of a Vesicle System Associated with Endoplasmic Reticulum in Exo‐Erythrocytic Forms of Plasmodium berghei1

    Article • The Journal of Protozoology, February 1983, Wiley

    Dr Jacques F Meis

  516. Degenerating exo-erythrocytic forms of Plasmodium berghei in rat liver: an ultrastructural and cytochemical study

    Article • Parasitology, October 1982, Cambridge University Press

    Dr Jacques F Meis

  517. The demonstration ofPlasmodium berghei sporozoites in rat hepatocytes one hour after inoculation

    Article • January 1982, Springer Science + Business Media

    Dr Jacques F Meis

  518. Effects of external osmolality, calcium and prolactin on growth and differentiation of the epidermal cells of the cichlid teleost Sarotherodon mossambicus

    Article • Cell and Tissue Research, November 1981, Springer Science + Business Media

    Dr Jacques F Meis

  519. An ultrastructural study of developing stages of exo-erythrocytic Plasmodium berghei in rat hepatocytes

    Article • Parasitology, April 1981, Cambridge University Press

    Dr Jacques F Meis

  520. Comparison of a few systems for the determination of saprobic and trophic degree on the basis of plankton data

    Article • Hydrobiologia, February 1980, Springer Science + Business Media

    Dr Jacques F Meis